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Foreword 
ILRAD—the International Laboratory for Research on Animal Diseases—was formally initiated 
10 years ago, on 17 September 1973, when the Government of Kenya signed a memorandum of 
agreement with the Rockefeller Foundation acting on behalf of the Consultative Group on 
International Agricultural Research (CGIAR). The CGIAR is an association of private 
foundations, national governments and regional and international organizations which support a 
network of agricultural research centres and programs around the world. The agreement with 
Kenya set out the mandate, the activities and the institutional arrangements for ILRAD's 
establishment. 
This agreement emphasized the importance of livestock production as a source of food supply, 
particularly on the African continent. The authors stressed the importance of two diseases which 
severely limit animal production in Africa—trypanosomiasis and East Coast fever (ECF), a form 
of theileriosis. Efforts to improve livestock productivity by upgrading existing herds, introducing 
better management systems and developing grazing resources will depend very largely on 
progress in bringing these two diseases under control. 
The animal health problems which led to ILRAD's establishment 10 years ago are, in certain 
areas, still as pressing as ever. Food production in Africa is actually falling, while population 
growth figures are the highest in the world. We can no longer expect to increase food supplies 
substantially simply by bringing additional land under cultivation or by dramatic improvements 
in farming technology: new opportunities in both these areas are limited. Yet in Africa and 
elsewhere in the world, millions of cattle, sheep and goats die each year from disease. And 
substantial productivity losses and treatment costs are incurred when animals are diseased, even 
if they survive. 
The two most important livestock diseases on the African continent are still trypanosomiasis and 
ECF. Scientists from many countries have been working for decades to develop effective 
methods to control these diseases, but this task has proven very difficult due to the complex 
nature of the diseases and their vectors. 
ILRAD's laboratories and support facilities were largely completed and occupied 5 years ago. 
The complex at Kabete, near Nairobi, was inaugurated on 5 April 1978 by President Daniel arap 
Moi, then Vice-President of Kenya. In 5 years of operation, ILRAD scientists have made 
substantial progress, both in defining the nature of the problems to be solved and in initiating the 
research required for their solution. However, there are still no quick or easy solutions in sight. 
We must therefore review our programs and plans—regularly and carefully—to ensure that we 
are adopting the right approaches. We must also consider what we can do now to improve the 
control of these diseases, with existing knowledge and the research results obtained to date, 
while we continue to search for effective long-term solutions. 
These issues were given full attention in 1982, with the aim of making ILRAD's research 
programs as relevant and effective as possible. We have moved away from the former individual 
laboratory organization, and attention now concentrates on projects with clear disease-control 
objectives. 
Research on theileriosis has been organized in three project areas. One area is an expanded ECF 
epidemiology project, based on the application of existing knowledge to improve control of the 
disease. Earlier work had shown that it is possible to immunize cattle against ECF by infecting 
them with live parasites and treating them with a tetracycline antibiotic. This method has not 
been fully exploited in the field because its value has been in doubt on several counts. Concern 
centred on the problem of strain differences and on the fact that animals immunized in this way 
might retain live parasites in their bloodstream and thus act as disease carriers. It has now been 
shown that cattle which recover naturally from ECF can also retain parasites in their 
bloodstream, so the occasional retention of parasites in the blood of immunized animals is no 
longer considered such a serious problem. ILRAD's theileriosis epidemiology project is 
exploring the practical value of this 'infection and treatment' method of immunization at several 
locations in Kenya. 
While there is some progress in this area, large-scale immunization using live Theileria parasites 
will probably never be fully satisfactory because it involves a certain amount of risk and because 
it is difficult to obtain enough live parasites. ILRAD's other theileriosis research projects are 
pursuing two possible alternatives for the development of a more acceptable vaccine. These are 
antigens from Theileria sporozoites, the form of the parasite which is transmitted to cattle from 
infected ticks, and antigens from Theileria schizonts, the form which develops in the cells of 
infected cattle. 
The trypanosomiasis research program has also been organized into three project areas. Again, 
one component is an epidemiology project. Techniques developed in the laboratory to identify 
and categorize trypanosome isolates are being applied in a field situation at the Kenya coast 
where the number of trypanosome strains is likely to be limited. Results from this work will 
allow us to assess the value of attempting to develop a vaccine based on tsetse transmitted 
trypanosome antigens. Such an approach might be successful in situations where there are only a 
few parasite strains. This work is particularly relevant to Trypanosoma brucei gambiense 
infections in man and may shed light on the possible role of domestic livestock as reservoirs for 
this pathogen. 
Another component of ILRAD's trypanosomiasis epidemiology project involves collaboration 
with the International Livestock Centre for Africa (ILCA) and the International Centre of Insect 
Physiology and Ecology (ICIPE) in studying the productivity of trypanotolerant livestock at 
several sites in Central and West Africa. ILRAD's role is to help train field staff involved in the 
research network and to standardize techniques for assessing levels of tsetse challenge and the 
incidence of trypanosomiasis. 
Research on trypanosomiasis in the laboratory is broadly based. We are following a number of 
promising research leads, but lines of work with assured practical applications are not easy to 
identify. One major research area centres on the development of methods to control the parasites 
themselves. The other area concentrates on improving the responses of infected animals.  
The introduction of a project structure to the research program at ILRAD has required few 
changes in existing facilities or staff. We now have one immunology laboratory and two 
immuno-parasitology laboratories, dealing separately with theileriosis and trypanosomiasis. The 
established laboratories continue their work in cell culture, molecular biology, biochemistry, 
pathology and electron microscopy.  
Senior members of staff have been designated as project leaders to coordinate work in each area, 
under the guidance of the Director of Research who was appointed in December. While these 
changes were being introduced, we continued to make steady research progress, as will be 
described in the following sections of this report. 
With the modern facilities and multidisciplinary staff assembled at ILRAD, there are many 
opportunities to train young scientists, technicians and field workers without serious diversion 
from research objectives. The program of individual training in the laboratories and the schedule 
of courses, conferences and workshops are both expanding steadily, as will be described in detail 
further on. By widely distributing information on training opportunities, we are ensuring that 
participation is available to individuals from as many countries as possible. To let more people 
know what we are doing and what assistance we can offer, we have prepared articles for outside 
publication and brochures in English and French describing various aspects of the research and 
training programs. The annual report is also now produced in both languages. 
In times of financial stringency, there is always concern that funds are put to the most effective 
use, and possibilities for effective collaboration become particularly important. ILRAD scientists 
are involved in a wide range of collaborative projects with colleagues in Kenya, in other parts of 
Africa, in Europe and North America. The research institutes, government projects and 
university departments involved in these collaborative projects are mentioned throughout this 
report. 
ILRAD's research program is guided by an international Board of Directors under the leadership 
of the Chairman, Dr K.F. Wells. Two members of the Board retired in 1982—Dr B.K. Na'isa and 
Prof Dr D. Zwart. Their substantial contribution to ILRAD's development over the years has 
been greatly appreciated. I would like to welcome three new Board members who were 
appointed in 1982—Dr D.M. Chavanduka, Prof E.N.W. Oppong and Prof W.R. Pritchard. 
Scientists and livestock development specialists from many parts of the world visited ILRAD in 
the course of the year. The Kenyan Minister for Livestock Development, the Hon Mr Paul Ngei, 
visited ILRAD in April to open the annual meeting of the Board of Directors. In October, the 
Minister for Regional Development, Science and Technology, the Hon Mr Nicholas Biwott, 
came to ILRAD to open a Training Course on the Use of Immunological Methods in the 
Diagnosis of Haemoprotozoan Diseases. Other important visitors included their Excellencies the 
Ambassadors of Belgium, the Netherlands and Switzerland and the High Commissioners of 
Australia and Canada. 
I would like to take this opportunity to thank the donors who have provided the financial support 
necessary to carry out our research and training activities. Over the years, funds have been 
provided by the World Bank (International Bank for Reconstruction and Development—IBRD), 
the United Nations Development Program (UNDP), the International Atomic Energy Agency 
(IAEA), the Rockefeller Foundation and the governments of Australia, Belgium, Canada, the 
Federal Republic of Germany, Ireland, the Netherlands, Norway, Sweden, Switzerland, the 
United Kingdom and the United States of America. In addition, it is a pleasure to acknowledge 
the continuing friendship and support of the people and Government of Kenya. 
In conclusion, after 5 years of full operation, we are beginning to see positive results from our 
research and training programs. ILRAD is already carrying out epidemiology projects in field 
situations where research findings from the laboratory are being applied in a practical way. We 
are training scientists, technicians and field workers from many countries who will provide a 
nucleus of personnel to improve the diagnosis and control of trypanosomiasis and theileriosis. 
We look forward to another active and productive year of research and training in 1983. 
A R Gray 
Director General 
ILRAD 
  
Theileriosis 
Theileriosis is a complex of parasitic diseases which affects cattle, and sometimes sheep, goats 
and domestic buffalo, in Africa, the Middle East and Asia. Figure 1 shows the distribution of the 
three major Theileria species which affect cattle throughout the world. Research at ILRAD 
concentrates primarily on ECF, the form of theileriosis which causes substantial losses among 
cattle in East and Central Africa. 
 
Figure 1. World distribution of Theileria parasites. 
ECF is caused by the protozoan parasite Theileria parva, transmitted by the brown ear tick 
Rhipicephalus appendiculatus. Two subspecies of the parasite are found in Kenya, T parva 
parva which occurs in cattle and T p lawrencei which normally occurs in buffalo but can cause 
severe infections in cattle. Two related species, T taurotragi and T mutans, may also cause 
infections in cattle. 
At present ECF is controlled primarily by dipping or spraying susceptible animals with 
acaricides to kill the tick vectors. In areas of heavy tick infestation, cattle must be dipped or 
sprayed at least twice a week. Drugs to cure ECF are being developed by commercial firms, but 
neither frequent treatment with acaricides nor regular drug treatment is feasible for many African 
livestock producers. Tick resistance to currently available acaricides is also potentially a serious 
problem. 
The life cycle of the T p parva parasite is depicted in Figure 2. Ticks may feed on cattle three 
times during their lives—as larvae, as nymphs and as adults. ECF sporozoites develop in the 
salivary glands of infected ticks and are transmitted to cattle when the ticks next feed. These 
sporozoites invade bovine lymphoid cells where they develop into macroschizont forms which 
multiply rapidly. The infected lymphocytes are transformed into enlarged blast cells, which are 
stimulated to multiply along with the parasites. Thus, the number of parasitized cells increases 
rapidly. In the final stages of the disease, large number of lymph cells are destroyed, and usually 
the animal dies. 
 
Figure 2. Lifecycle of T p parva. Sporozoltes are transmitted to the bovine host in tick saliva. 
They enter the lymphocytes and develop into macroschizonts. After a period of nuclear division, 
these give rise to numerous micromerozoites which escape from the lymphocytes and enter the 
erythrocytes where they are ingested by feeding ticks. In the tick gut the parasites differentiate 
into male and female gamonts which fuse to form zygotes. These enter the cell lining of the gut 
where they differentiate into kinetes. The kinetes traverse the gut wall and become free in the 
tick's body cavity. They move to the salivary gland and enter one cell type, the E-cell of the type 
III acinus. Here they form an elaborate intracellular sporoblast syncytium which undergoes 
segmental fission and gives rise to 30,000 to 50,000 sporozoltes. These are introduced with the 
saliva into a new mammalian host, initiating a new cycle of parasite development. 
During the course of infection, some of the macroschizonts change to microschizonts. These give 
rise to micromerozoites which are released and infect red blood cells. The parasites are then 
transmitted back to ticks which ingest the infected cells. 
Mortality rates in fully susceptible cattle can approach 100%. However, animals which recover 
from infection show long-lasting immunity to the same or similar disease strains. This resistance 
to reinfection suggests that prospects are promising for the development of an ECF vaccine. The 
precise mechanisms of immunity remain unclear, but it is likely that both antibody production 
and cell-mediated immune responses play a role. 
Scientists at ILRAD are studying both the sporozoite and the macroschizont stages of parasite 
development and associated host responses in an effort to develop a safe and effective ECF 
vaccine. ILRAD's third project area, theileriosis epidemiology, includes the identification and 
classification of disease strains isolated in the field, the improvement of experimental 
immunization procedures based on infection with live parasites and antibiotic treatment, and a 
collaborative investigation of the role of buffalo and other wild animals as disease carriers. 
Collaborative research was also carried out in 1982 on immune responses to tick saliva and other 
tick proteins and on the possibility of immunizing cattle against the tick vector. 
Towards a sporozoite vaccine 
The development of sprozoites in the tick 
Electron microscope studies at ILRAD have concentrated on the development of Theileria 
sporozoites in tick salivary glands. A better understanding of this process could help increase 
yields of sporozoites from infected ticks. Eventually, these studies could also make it possible to 
isolate sporozoite antigen mRNA as a basis for producing the antigen in vitro. 
Work in 1981 concentrated primarily on T p parva. It was extended in 1982 to cover the related 
species and subspecies, T taurotragi and T p lawrencei, more fully. This research has shown that 
sporozoites do not develop by repeated binary fission, as previously assumed. Rather, in the E 
cell of the type III acinus, a Theileria sporoblast develops into a syncytium, a large, ramifying 
mass of parasite protoplasm. Thousands of nuclei proliferate throughout the syncytium, forming 
sporozoites in an episode of terminal fission. Detailed studies in 1982 showed that these nuclei 
are produced by mitotic division involving dispersal and reconstitution of the nuclear envelope. 
The divisions are not precisely synchronized. 
Attention has also focused on the development of cellular organelles in the sporozoite which may 
play an important role when the parasite enters and develops in a bovine lymph cell. Theileria 
sporozoites do not necessarily contact and enter bovine lymphocytes at the point where the 
rhoptries are attached to their surface membrane. In this they differ from other intracellular 
protozoan parasites. The role of the rhoptries in the initiation and development of Theileria 
infections remains unclear. Electron microscope studies in 1982 showed that the rhoptries arise 
near the nuclei in the Theileria syncytium during the final nuclear division, in close association 
with the spindle-pole bodies. They subsequently attach to a neighbouring subplasmalemmal 
dense plaque which transforms into a membrane-bounded cistern (see Figure 3). 
 
Figure 3. Schematic depiction of the origin of the rhoptries in the development of a Theileria 
sporozoite. A: rhoptries appear to arise by polymerization of molecular subunits and are initially 
arranged radially around the spindle-pole bodies during the final nuclear division in the 
sporoblast syncytium. B: their tapering ends later attach to a stem projecting inward from a 
subplasmalemmal dense plaque. C: the dense plaque is subsequently transformed into a 
membrane-bounded cistern closely associated with the membrane of the sporozoite. 
Small secretory granules, called micronemes, are found in sporozoite cytoplasm. They may play 
a role in the dissolution of the host cell membrane after the entry of the parasite. Research in 
1982 showed that the micronemes form after the rhoptries and increase in size and number 
during the maturation of the sporozoite. No evidence was found for their derivation from the 
rhoptries: rather, they appear to be assembled independently from molecular precursors. The 
possible role of the micronemes in the parasite's evasion of host cell defence mechanisms is now 
being studied in more detail. 
Preliminary investigations in 1981 suggested that the ultrastructure of T p parva, T p lawrencei 
and T taurotragi sporozoites may be sufficiently distinctive to identify the species of parasite 
found in feeding ticks. Sporozoites of different species and subspecies are probably more 
difficult to distinguish at a later stage when they are released into the mammalian host. In 1982, 
sporozoites harvested from infected ticks were examined with the electron microscope, and 
minor but consistent differences were found between the three Theileria species and subspecies 
in terms of shape, electron density, residual bodies and number and kind of micronemes. 
T taurotragi sporozoites, shown in Figure 4, are quite variable in shape and commonly possess a 
single tail-like process. Their surface coat is thicker and their rhoptries are larger than those of 
the other species. Figure 5 shows T p lawrencei sporozoites. They are more dense and more 
variable in shape than T p parva sporozoites and often contain multivesicular bodies not seen in 
the other species. They also develop micronemes at a later stage. Sporozoites of T p parva are 
uniformly ovoid or spherical, as shown in Figure 6. Their cytoplasm is less dense and their 
surface coat less well developed than the other two species. Theileria sporozoites can also be 
distinguished by electron microscope examination from comparable developmental stages of 
other parasites, such as Babesia. 
 
Figure 4. Newly formed sporozoites of T taurotragi are highly variable in shape. Many have tail-
like projections (see at arrows). 
 Figure 5. Sporozoites of T p lawrencei are variable in form, but less so than those of T 
taurotragi. The mitochondrion is small and micronemes appear relatively late 
 
Figure 6. Sporozoites of T p parva are more uniformly round or oval than sporozoites of T 
taurotragi or T p lawrencei. They appear slightly larger, their cytoplasm is less dense and their 
micronemes are more numerous than in the other two species. 
Sporozoite antigens and immune responses 
Scientists at ILRAD have shown that cattle infected with T p parva produce neutralizing 
antibodies against parasite sporozoites. In 1982, anti-sporozoite antibodies were taken from 12 
cattle infected with T p parva Muguga, a strain isolated at the former East African Veterinary 
Research Organization. These antibodies were tested in vitro for their ability to neutralize 
sporozoites of five different East African Theileria strains—T p parva Uganda, T p lawrencei, T 
p parva Kiambu 5, T p parva Marikebuni and T p parva Kabete 1. The antibodies raised against 
the Muguga strain neutralized the infectivity of sporozoites of all these strains. Similar 
observations were recorded using anti-sporozoite antibodies raised against T p parva Uganda and 
T p lawrencei. These results were unexpected, as some of these strains are known not to cross 
protect. 
In a further study, 6 of the 12 original cattle were challenged repeatedly with T p parva Uganda 
and the other 6 with T p lawrencei. Those animals with high titres of anti-sporozoite antibodies 
were completely protected, while those with low levels of antibodies became infected, 
suggesting the role of antibody in the protective immune response. It was concluded that either a 
common protective antigen is found on sporozoites of all the strains covered in the study, or, if 
several antigens are involved, the relevant ones are represented on every strain. 
The next step was to determine whether one antigen or a mixture of antigens stimulated the 
observed immunity and to identify precisely the antigen(s) involved. This work has been 
undertaken by raising monoclonal antibodies against the Theileria sporozoites. Monoclonal 
antibodies are produced experimentally by creating hybrid cells from the fusion of mouse spleen 
cells, which produce antibodies, and mouse myeloma cells, derived from bone-marrow. The 
hybrid cells are capable of growing and dividing in culture and are primed to respond to specific 
parasite antigens. The development of this technology has been an important component of 
research work at ILRAD, with many applications in the study of both theileriosis and 
trypanosomiasis. 
To produce monoclonal antibodies to sporozoite antigens, purified sporozoite preparations were 
used as starting and screening material. As part of this project, ILRAD immunologists have 
developed a new method for purifying sporozoites. Scientists producing monoclonal antibodies 
in the past have most often used homogenates of whole infected ticks as starting material, partly 
purified by successive steps of centrifugation and sometimes by Percoll density gradients. When 
examined under the electron microscope, however, these. preparations prove to be highly 
heterogeneous, containing a variety of components, such as secretory granules, mitochondria and 
secretions from the ticks' Malpighian tubules, which are similar to sporozoites in terms of size 
and specific density. With the new technique, material from infected tick salivary glands is 
separated by passage through columns of diethylaminoethyl cellulose. The purity of the fractions 
obtained is monitored with the electron microscope.  
Using sporozoites purified in this way, five highly specific IgM monoclonal antibodies were 
produced against T p parva Muguga. All five antibodies appear to recognize the same antigen. 
They also neutralize the infectivity of T p parva Uganda and T p lawrencei sporozoites as well as 
those of the Muguga strain, suggesting that sporozoites of these strains share a common antigen. 
Since these three strains were isolated from widely separated locations, it is possible that their 
common antigen may be found in other East African Theileria populations. This suggests that it 
might be possible to develop a vaccine based on this antigen which would protect cattle over a 
wide area. With this aim, scientists are now testing the five antibodies against other Theileria 
strains from different locations. 
The method for purifying sporozoites which was developed as part of this project has a number 
of other potentially useful applications. Cattle can now be immunized experimentally with much 
purer sporozoite preparations than were available in the past. If sporozoite production can be 
scaled up to yield larger numbers, it will also be possible for the first time to study the 
biochemistry of the sporozoite surface membrane and organelles. 
Another technique was developed in 1982 for screening monoclonal antibodies which recognize 
sporozoite antigens. Monoclonal antibodies raised in mice are screened using an immuno-
autoradiography assay system which makes it possible to distinguish precisely which antibodies 
recognize sporozoite antigens. Cryostat sections are prepared from infected tick salivary glands 
and the monoclonal antibodies are added. These bind to antigens in the preparation. A 
radioactive-labeled anti-mouse antibody is then added which binds to the mouse-produced 
monoclonal antibodies. The preparation is stained with Feulgen to reveal the location of parasite 
DNA; this is done to ascertain which salivary gland acini contain parasites. The preparation is 
then covered with a photographic emulsion which is exposed wherever the radioactive-labeled 
anti-mouse antibody adheres to a sporozoite antigen/monoclonal antibody complex, as shown in 
Figure 7. 
 
Figure 7. Detection of anti-sporozoite antibodies in hybridoma culture fluids by immuno-
autoradiography: autoradiograph of an infected acinus (arrow) in sequential sections through 
an infected salivary gland, incubated with either anti-sporozoite (left) or control (right) 
antiserum. Uninfected acini (U) are not labeled. Salivary glands from R appendiculatus ticks, 
heavily infected with T p parva sporozoites, were collected and 5 µm cryostat sections prepared, 
mounted on slides, fixed in 0.25% glutaraldehyde for 5 min and stored at –20°C. Sections were 
thawed, washed once with phosphate-buffered saline (pH 7.4) containing 1 % bovine serum 
albumin and 0.05% sodium azide (washing buffer-WB), incubated for 45 min with 20 µl of the 
culture supernatant being tested for the presence of monoclonal antibody, and washed 3 times 
with WB. Sections were then incubated for a further 45 min with 20 µl of a mixture of 125 1-
labeled goat anti-mouse IgG and IgM (2 × 104 cpm for each), washed 3 times with WB and 
dried. To demonstrate parasite DNA inside the infected salivary gland acini, preparations were 
fixed at. room temperature for 1 h with 5N HCI and stained for 1 h with Schiff 's reagent: The 
slides were then dipped in photographic emulsion (Ilford L4) and left to dry and expose 
overnight. Preparations were then developed, fixed and examined microscopically. The presence 
of silver grains over an infected acinus indicates specific binding of the antibody to sporozoite 
antigen within the acinus. 
This assay system was used to screen 360 monoclonal cell lines, and 5 were identified which 
showed strong antibody activity to T p parva Muguga sporozoites. One IgG3 antibody, MAbD1 
was selected for further neutralization studies. In vitro experiments showed that this antibody 
neutralizes sporozoites of T p parva Muguga, T p parva Uganda and two strains isolated from 
the Kenya coast, T p parva Mavueni and T p parva Marikebuni. When sporozoites of these 
strains were incubated with the MAbD1 antibody diluted at a rate of 1:1000, they were inhibited 
from infecting bovine peripheral blood leucocytes (PBL), whereas bovine PBL were infected by 
sporozoites incubated with a control antibody (MabV3), as shown in Figure 8. The activity of this 
antibody was confirmed by in vivo tests: four out of six cattle inoculated with T p parva Muguga 
sporozoites treated with different concentrations of the MAbD1 antibody did not become 
infected, while two others became infected but recovered. Animals inoculated with sporozoites 
treated with a control antibody all died. 
Isolate 
Antibody 
Dilution 
% Wells showing Cell line 
establishment 
      
MAbD1 MAbV3 
T p parva 
Muguga 
   
  
   
10–1 0 100 
10–2 0 100 
10–3 0 100 
10–4 100 –* 
T p parva 
Uganda 
   
10–1 0 100 
10–2 0 –* 
10–3 0 –* 
10–4 0 –* 
  
   
T p parva 
Mavueni 
   
  
   
10–1 0 96 
10–2 0 –* 
10–3 0 –* 
10–4 0 –* 
T p parva 
Marikebuni 
   
  
   
10–1 12 100 
10–2 0 –* 
10–3 8 –* 
10–4 96 –* 
*Test not done. 
Figure 8. Inhibition of Theileria infection in bovine PBL by the MabD1 monoclonal antibody and 
a control antibody (MabV3). Fresh sporozoites were prepared from R appendiculatus salivary 
glands infected with T p parva stocks. Glands were dissected out under aseptic conditions and 
homogenized in a tissue grinder in complete L15 medium. After centrifugation at 50 g for 5 min, 
the supernatant was collected and adjusted to an equivalent of 100 ticks/m–1. Twenty µl of 
MAbD1 diluted in L15 were added to 20 µl of sporozoite preparation to give final antibody 
dilutions of 10–1,10–2, 10
–3
, or 10
– 4. After 30 min incubation on ice, 5 µl of undiluted rabbit 
complement (C') was added and the mixture incubated a further 30 min at 37o C. Where 
appropriate, the monoclonal antibody MAbD1 was substituted by complete L15 or by the control 
antibody MAbV3. After incubation with antibody and C', 2.5 × 10
5 PBL isolated on Ficoll-
Hypaque (in 10 µl of complete L15) were mixed with the sporozoite preparations and left for 1 h 
at room temperature. The cells were then washed, resuspended in 2.5 ml complete L15, and 100 
µl aliquots dispensed onto a feeder layer derived from fetal bovine thymus in 24 wells of a flat 
bottomed 96-well microtiter plate. The final volume in each well was 200 µl and the medium was 
replenished every 3 days by replacing 100 µl with fresh complete L15. Plates were examined 
weekly for 3 to 5 weeks and the number of wells with cell growth was determined. 
These results and those of the first study suggest that protective immunity against Theileria 
infections may involve the production of specific antibodies. Having shown that anti-sporozoite 
antibodies can neutralize Theileria sporozoites in vitro, ILRAD scientists are now investigating 
their possible role in protecting cattle from infection. Both 1982 studies also suggest that strains 
of T p parva isolated from widely separated locations may share a common antigen which might 
be used as the basis for an effective vaccine. 
Further work is in progress to isolate and characterize the sporozoite antigens which generate a 
protective immune response. These antigens are probably proteins, but their chemical nature is 
being investigated to rule out the possibility that they might be carbohydrates or lipids. 
Sporozoite antigens which are likely to be proteins are being identified according to their 
molecular weight using immunoautoradiographic techniques. One protein has been identified 
with a molecular weight of about 105,000 daltons which is specific to Theileria sporozoites. If 
the relevant antigen(s) can be precisely characterized, appropriate DNA could possibly be cloned 
in bacteria, using recombinant DNA technology, or artificially synthesized to produce sufficient 
quantities for use in immunization trials. 
Development of a vaccine based on schizont-infected cells 
Cattle can be immunized experimentally against ECF by inoculating them with bovine lymph 
cells which are infected with Theileria macroschizonts. For successful immunization to occur, 
the macroschizonts must leave the foreign cells and somehow enter and transform the host's own 
cells. Before this can happen, the animal's immune system tends to reject the foreign lymphoid 
cells. This problem can be overcome by taking cells from the animal to be immunized, infecting 
them with sporozoites in vitro and injecting them back into the same animal. Another approach is 
to use very large numbers of infected foreign lymphoid cells (about 100 million) so that at least a 
few survive the initial rejection effect. However, neither of these approaches is fully safe or 
practicable for widespread application. A full understanding of the way macroschizonts transfer 
between cells and the associated host responses could lead to an improved vaccine based on 
schizont-infected cells or other measures which would prevent or modify the effects of the 
disease. 
In clinical cases of ECF, infected cells stimulate other cells to multiply and to kill surrounding 
cells. Changes on the surface of the parasitized cells are thought to trigger these different 
responses. Scientists at ILRAD are investigating precisely what types of cells are infected by 
Theileria sporozoites, what changes occur on these cells, how these changes are induced by the 
macroschizont, and what responses they stimulate in other cells. 
Researchers elsewhere have shown that vertebrate cells have genes whose products regulate cell 
proliferation, some inducing and others inhibiting growth. Tyrosine protein kinases induce cell 
growth and proliferation, while a protein phosphatases inhibit growth, producing a normal 
balance. The uncontrolled growth of Theileria-infected cells can be viewed as a breakdown of 
these normal homeostatic controls: the Theileria macroschizont may produce or induce the 
production of excessive amounts of tyrosine protein kinase or inhibit the synthesis or function of 
protein phosphatases which control the growth process. 
A variety of techniques and assay systems are being developed at ILRAD to investigate these 
possibilities. The products of cells parasitized with T p parva and T p lawrencei are being 
screened to identify growth-promoting factors as well as toxic products which eventually lead to 
cell destruction. 
Other studies carried out in 1982 concentrated on the types of cells which are infected by 
Theileria parasites. Scientists raised monoclonal antibodies which recognize specific types of 
bovine lymph cells. These were used to examine how many bovine cell types can be infected in 
vitro by different strains of T p parva sporozoites and which types are transformed into enlarged 
blast cells containing parasite macroschizonts. This investigation has shown that some B-cells, 
several subpopulation of T-cells and at least one monocyte population can be infected and 
transformed by the parasite in vitro. However, preliminary studies indicate that fewer cell types 
are actually involved in lethal infections in cattle. These observations suggest that Theileria 
parasites may infect many cell types in cattle but the host may control the proliferation of some 
cell types while other types are uncontrollable. 
Studies are now in progress to determine what makes one infected cell type less controllable than 
another. Scientists are also investigating whether the cells which become uncontrollable in 
different animals display common antigens when the animals are infected with the same 
Theileria strain and whether different Theileria strains infect and transform different cell types. 
Earlier studies indicated that parasitized cells are not induced to proliferate by a simple early 
event, but rather that the continuous presence of a Theileria macroschizont is required to 
maintain the proliferative state. As host cells are stimulated by Theileria macroschizonts to 
divide, some cells are produced which are free of parasites. Comparative studies of parasitized 
and non-parasitized daughter cells are being carried out to determine the factors and metabolic 
pathways involved in the maintenance of the parasitized state. When parasitized cells are cloned 
in vitro, a consistent proportion of parasite-free daughter cells is produced, ranging from 1 to 
15% for different cell lines. These non-infected cells are viable, though they appear to stop 
dividing or divide at a much lower rate than the infected cells. Evidence suggests that non-
parasitized cells originate from abnormal cell divisions with the Theileria macroschizont nuclei 
all transferred to one daughter cell. 
The terminal stage of ECF is characterized by massive cell destruction, but there is also evidence 
that cytotoxic (cell-killing) responses are involved in the acquisition of immunity. The different 
between the two situations appears to lie in the specificity of the response. In fatal cases of ECF, 
an animal generates cytotoxic cells which indiscriminately kill its own parasitized and non-
parasitized cells: these cytotoxic cells are also capable of killing parasitized and non-parasitized 
cells from other animals. By contrast, if an animal has acquired immunity to a particular strain of 
the parasite and is rechallenged with the same or similar strain, cytotoxic cells are generated 
which kill only parasitized cells of that animal, thus ridding it of infection. 
The specificity of the cytotoxic response in immune cattle probably involves recognition of 
major histocompatibility complex MHC antigens. In other animal species, these antigens act as 
targets for cytotoxic responses to virus-infected or foreign cells. Researchers elsewhere have 
identified a series of class 1 MHC antigens in cattle. During the past year, a study was carried out 
in collaboration with the Veterinary Research. Department of the Kenya Agricultural Research 
Institute which demonstrated clearly that these MHC antigens act as targets for cytotoxic cells 
(Figure 9). Further studies are in progress to determine whether specific killing of Theileria-
infected cells by cytotoxic cells also involves recognition of these MHC antigens. 
 
Figure 9. Bar charts showing levels of cytotoxicity generated in an allogeneic mixed leucocyte 
reaction (MLR) using responder bovine PBL from one animal (B470) with stimulator PBL from 
two different animals (S811 and S812). Cytotoxicity levels were measured in a 51 Cr release 
assay on a series of target cell lines which were matched (columns 1–5), semimatched (columns 
6–13) or mismatched (columns 14–18) with the stimulator cells with respect to class 1 antigens 
coded by the A locus of the bovine MHC. The level of cytotoxicity attained closely correlated 
with the degree of sharing of these MHC determinants. Thus, the level of cytotoxicity was high 
not only on the cells of the animals used to stimulate the response (solid columns), but also on 
cells fully matched with the stimulator. Very low levels of cytotoxicity were obtained on 
mismatched targets, while the level of cytotoxicity on semimatched targets was intermediate. 
Another study was carried out to identify specific antigens on the surface of Theileria infected 
cells. First, cattle cells were infected in vitro with T p lawrencei sporozoites of a strain originally 
isolated from a buffalo. A monoclonal antibody (J7) was raised against these cells and was found 
to recognize an antigen on the surface of some of the cells, but not others. The antigen was not 
present on any non-infected cells. Using the fluorescence-activated cell sorter (FACS) and 
monoclonal antibodies available at ILRAD to distinguish different populations of bovine cells, it 
was shown that the cells which express the antigen are all of a particular type. Further studies 
have shown that the antigen is not produced by the parasite itself, but is probably induced on one 
type of host cell type by the presence of the parasite. 
It may be possible to immunize animals with non-infective preparations of parasitized cells 
which will stimulate the specific cytotoxic responses that appear to confer immunity. Two 
approaches were investigated in 1982. In one study, cattle were immunized with cell membrane 
preparations made from infected cell lines. Three out of four animals immunized with 
preparations from their own cells proved immune to a lethal dose of T p parva sporozoites, 
whereas three animals inoculated with preparations from the cells of other animals were fully 
susceptible. The finding that some animals can be immunized with cell membranes prepared 
from their own Theileria-infected cells supports the hypothesis that protective immune responses 
are directed against antigens on the cell membrane and that such responses are restricted by the 
host genotype. 
In further experiments, the responses of bovine lymphocytes to infected cell membranes were 
monitored to determine whether proliferative responses in vitro reflect an animal's immune 
status. When membranes from infected cells were added to lymphocytes taken from the same 
animal, they did not stimulate any proliferation, either in naive or immune cattle. However, if the 
membranes were added to macrophages (a cell type which presents antigens to lymphocytes) and 
then mixed with lymphocytes, they sometimes stimulated a strong proliferative response. 
Proliferation was observed in cells from cattle which had been immunized with membrane 
preparations, but not in cells from cattle which had been immunized by infection with 
sporozoites and treatment. A proliferative response was also observed in one non-immune 
animal which had been injected with irradiated Theileria-infected cells. These findings suggest 
that the antigen on the cell membrane which stimulates a proliferative response is present only 
on infected cells cultured in vitro, and is therefore probably not involved in stimulating 
protective immunity in cattle. 
Cattle have also been inoculated experimentally with intact cells grown in vitro and rendered 
non-infective by irradiation. Large doses of irradiation were required to completely neutralize the 
infectivity of the cells. Cattle inoculated with these cells showed some cytotoxic responses when 
challenged with sporozoites but still became infected. The failure to achieve immunity despite 
the detection of cytotoxic responses could suggest that other responses may be required for 
protective immunity, that the cytotoxic responses measured are directed against a number of 
different antigens, not all of which are relevant, or that the specific host cell types infected in 
vitro are different from the cell types infected by challenge with sporozoites. 
Epidemiology and experimental ECF control 
Cattle inoculated with T p parva sporozoites and treated stimultaneously with a long-lasting 
oxytetracycline antibiotic (Terramycin LA-Pfizer) often develop no or only mild disease 
symptoms and subsequently resist infection by the same strain of the parasite. This 'infection and 
treatment' approach to immunization has several disadvantages, but it offers the most immediate 
possibility of improved disease control while work continues on the development of a safe and 
effective vaccine. 
One disadvantage is that different strains of T p parva are often not cross-protective: immunity 
conferred against one strain will not necessarily ensure protection against another. Secondly, not 
all strains can be controlled by oxytetracycline, so the initial infection with live parasites may be 
fatal. Finally, buffalo are often chronic carriers of ECF, and in areas where cattle come into 
contact with buffalo the pattern of parasite strains is often very complex, making control more 
difficult. 
Epidemiological studies at ILRAD focus on all these problems. The aim is to investigate and 
introduce improved control methods in restricted locations on a trial basis with the possibility of 
expanding over wider areas if the initial trials prove successful. 
Strain Characterizations 
The identification and classification of Theileria strains isolated in the field is an important 
component of ILRAD's epidemiology program. Until recently, the only way to identify specific 
strains of T p parva was by cross-immunity trials in cattle. These are expensive and imprecise. 
Now monoclonal antibodies are raised at ILRAD which can be used to screen macroschizont-
infected cells and identify parasite strains. 
By the end of 1982, a battery of 16 anti-macroschizont monoclonal antibodies had been raised 
and tested against 22 stocks of T p parva isolated from widely separated areas of Kenya, Uganda, 
Malawi and Zambia. The activities of the different monoclonal antibodies were measured using 
the indirect fluorescent antibody (IFA) test. Based on comparisons of these responses, all the 
stocks tested fell into one of three groups, as shown in Figure 10. The pattern of reactions 
remained the same after the stocks were passed through ticks or cattle. The groupings do not 
correlate with the geographic areas from which the stocks were obtained. 
 Figure 10. Responses of 16 monoclonal antibodies to macroschizonts of 16 T p parva stocks, 
measured by the IFA test. A total of 23 stocks from Kenya, Uganda, Malawi and Zambia have 
been screened. They all appear to fall into one of three profile groups (A, B and C), irrespective 
of geographic origin. 
The best material for obtaining profiles of monoclonal antibody reactions proved to be 
macroschizont-infected lymphoid cells taken from infected cattle and cultured in the laboratory. 
Profiles can also be obtained within hours from biopsy material taken from infected animals; this 
technique could be important in planning an immunization strategy to control a disease outbreak 
in the field. The reactions of monoclonal antibodies have also been measured experimentally by 
immuno-peroxidase reaction procedures, but this alternative approach has not yet been 
thoroughly evaluated. 
Cross-immunity trials were carried out in cattle to test the accuracy of the monoclonal profiles in 
characterizing disease stocks. Cattle were immunized experimentally against one Theileria stock 
and rechallenged with the same stock. Then they were challenged with another stock of the same 
antibody profile group or with a stock of a different profile group. The results are summarized in 
Figure 11. Animals challenged with the same stock as their original infection or with a stock of 
the same profile group showed very mild disease symptoms or none at all. By contrast, animals 
challenged with a stock of a different profile group often showed severe symptoms and some 
died. 
Type of challenge None Level of reaction (%) Number of cattle 
      
Moderate Severe Death 
   
Same stock 83 17 0 0 53 
Different stock, 
same profile group 
               
   75 25 0 0 16 
Different stock, 
different profile 
group 
               
   38 28 12 22 49 
Controls 0 3 23 74 34 
Figure 11. Reactions of cattle immunized experimentally against an ECF stock and challenged 
with the same stock or with a different stock from the same or another monoclonal antibody 
profile group. These results suggest that antibody profiles of T p parva isolates reflect cross-
protective patterns.  
Future work will concentrate on further correlation between monoclonal antibody reactions to 
different Theileria stocks and cross-protection in cattle. Monoclonal antibodies will also be used 
as markers in hybridization experiments. It may be possible to develop hybrid Theileria strains 
as the basis of a vaccine which will protect animals over a wide geographic area. 
Immunization trials 
Previous workers have immunized cattle against ECF by 'infection and treatment' with some 
success in field trials carried out in Kenya, Tanzania and Rwanda. In cooperation with the Kenya 
Ministry of Livestock Development and Agricultural Development Corporation, ILRAD 
scientists are examining this method in three areas at the Kenya coast where livestock 
management is good and the epidemiology of the disease is well understood. 
Several T p parva isolates were made from different sites at the coast, and stocks of each isolate 
have been produced and characterized according to their monoclonal antibody profiles. T p parva 
Kilifi and T p parva Marikebuni were selected as key stocks for immunization trials. Animals are 
immunized by injecting them with sporozoite material and treating them simultaneously with 
Terramycin. 
Scientists are investigating the earliest age at which calves can be safely immunized. This is an 
important consideration because the immunization of young animals results in early protection 
and lower costs. Also following ECF immunization, calves can be exposed to babesiosis, 
heartwater and anaplasmosis in the field. In this way, young animals can acquire immunity to 
these other tickborne diseases while they still retain a level of maternal resistance, whereas such 
a procedure would be hazardous for older animals. 
In one study, 2-week-old Boran calves were immunized at ILRAD as safely and effectively as 
older cattle. In a related experiment, 6-month-old calves were immunized and afterwards their 
weight gains were compared with those of untreated controls. Figure 12 shows that growth rates 
in the immunized calves were not affected either by the initial immunization or by subsequent 
disease challenge. 
 
Figure 12. Weight gains over 4 months of calves immunized against ECF at 6 months of age and 
challenged 7 weeks later with the same disease strain. Weight gains throughout the period were 
comparable to those of controls. 
Techniques are being developed to measure doses of sporozoite material more precisely. Other 
aspects of experimental immunization under study include the mechanisms of oxytetracycline 
action and the possibility of using other drugs or techniques for containing sporozoite-induced 
infections. This work has shown that if the dose of parasites is too high oxytetracycline may not 
be effective in containing the ensuing reaction and further treatment, such as with parvaquone 
(Clexon-Wellcome), may be necessary. However, when a lower dose of parasites is used, calves 
undergo a mild or inapparent reaction and are fully resistant to subsequent lethal challenge. 
This method is being examined under field conditions at three sites at the Kenya coast. A group 
of 18-month-old Boran cattle was immunized at ILRAD and transported to Mariakani with 
control animals. At Mtwapa, a group of Jersey calves was purchased and immunized locally. The 
third trial is being conducted at Malindi, where a group of Sahiwal/Red Poll cross calves has 
been immunized. When a single dose of oxytetracycline was administered to this third group, 
some calves needed additional treatment with parvaquone, but when oxytetracycline was given 
to the group at Mtwapa at the time of infection and again 5 days later, no adverse reactions were 
recorded. The response of the three cattle groups to field challenge is now awaited. 
If these experiments are successful, they will demonstrate that stocks of T p parva can be 
isolated, characterized and used to immunize cattle against local strains. The next step will be to 
extend similar trials to other areas in Kenya and to other countries. 
Theileria studies in wildlife 
African buffalo (Syncerus caffer) are chronic carriers of T p lawrencei which can cause high 
mortality in cattle. Figure 13 shows the distribution of cattle and buffalo in East Africa. In areas 
where cattle come into contact with buffalo, the pattern of Theileria strains becomes extremely 
complex and a breakdown in immunity can occur. In cooperation with the Kenya Government's 
Veterinary Research Laboratories, scientists at ILRAD are studying Theileria in wild animals 
and its transmission to domestic cattle. 
 Figure 13. Distribution of buffalo (Syncerus caffer) and cattle in East Africa. 
Work is in progress to define more precisely the relationship between T p lawrencei and T p 
parva. These two Theileria subspecies cannot be distinguished serologically, though there are 
indications that they may invade different types of cells. There is also some evidence that 
Theileria parasites carried by buffalo change antigenically over time. This would have serious 
consequences for attempts to immunize cattle against locally isolated stocks of ECF in areas 
where buffalo are present. To investigate this possibility, attempts are being made to infect a 
buffalo with a clone of T p lawrencei and to isolate parasitized cell lines from the animal 
sequentially for antigenic analysis. 
Aspects of tick biology and Theileria transmission 
It has been demonstrated that livestock and laboratory animals acquire resistance to tick 
infestation. Antigens secreted by the tick during feeding appear to stimulate a delayed-type 
hypersensitivity inflammatory response in the skin which makes the bite site unfavourable for 
the feeding process. In collaboration with ICIPE, scientists have analysed serum from rabbits 
resistant to R appendiculatus ticks using crossed immune electrophoresis in order to identify tick 
antigens which stimulate the hypersensitivity reaction. One promising antigen has been selected 
and is now being purified from tick salivary glands for further study. 
Research has also suggested that tick products may stimulate an immune response in the 
mammalian host which reduces the viability of eggs laid by the ticks after feeding. Rabbits were 
immunized with an extract of fed adult female ticks and scientists used crossed immune 
electrophoresis to identify 10 to 12 tick antigens recognized by the rabbits' sera. Antibodies were 
generated against four of these antigens and were used successfully to transfer the adverse effect 
on egg viability to feeding ticks. Precipitin line immunization will now be used to identify the 
specific antigen responsible for this effect and to analyse its synthesis and function. Eventually, 
this antigen or the antigen which stimulates resistance to tick bites may be used in experimental 
immunization trials. 
It has been hypothesized that tick saliva also contains substances which inhibit the immune 
responses of cattle, making them more susceptible to Theileria infection. Tick salivary gland 
extracts (TSGE) and saliva from infected and uninfected ticks have been screened for enzymes, 
enzyme inhibitors and anticoagulants which could play a role in circumventing host defences 
against tick infestation and transmission of infection. It has been shown that tick saliva and 
TSGE have a histamine inactivating enzyme and inhibitors of chymotrypsin and thrombin. Very 
little difference was found between infected and uninfected TSGE, indicating that the sporozoite 
contribution to these functions is minimal. Work is now in progress to purify some of the TSGE 
proteins and peptides. Eventually, cattle will be immunized with these proteins and assessed for 
any increased capacity to control tick infestation and ECF transmission. 
Earlier work at ILRAD indicated that Theileria sporozoites stimulate bovine lymphocytes to 
proliferate much more readily if the bovine cells are already multiplying in response to the 
mitogen Concanavalin A. This finding suggests that substances in tick saliva which stimulate a 
proliferative response may also make bovine lymphoid cells more receptive to sporozoite 
invasion. The stimulatory effect of TSGE on bovine leucocytes was tested in vitro, but so far 
result, have been inconclusive. 
  
Trypanosomiasis 
Trypanosomiasis is a serious, often fatal, parasitic disease which occurs in large areas of Africa, 
Latin America, the Middle East and Asia. It affects most species of domestic livestock, many 
types of wild animals, and man. In Africa, trypanosomiasis is found over approximately one-
third of the continent, as shown in Figure 14. 
 
Figure 14. Major cattle-production areas and tsetse-infested zones in Africa. There is little 
overlap except in the regions of West and Central Africa where trypanotolerant N'Darna and 
West African Shorthorn cattle are kept. 
Trypanosomiasis is caused by single-celled parasites which primarily invade the bloodstream. 
Different species of trypanosome infect different host species. The most important trypanosomes 
in economic terms are the tsetse-transmitted species which infect cattle, sheep and goats in 
Africa—Trypanosoma congolense, T vivax and T brucei sspp. Trypanosomiasis research at 
ILRAD focuses on these three species. 
In Africa, trypanosomes are usually transmitted by tsetse flies (Glossina spp) and occasionally 
by other biting flies. About 30 species and subspecies of tsetse are found in Africa. All of these 
are capable of transmitting trypanosomiasis, but some are more important vectors than others. In 
many parts of the world, trypanosomiasis is transmitted by other biting flies or occasionally 
sexually. Trypanosome species which are not transmitted by tsetse flies, such as T evansi cause 
significant livestock disease in Africa, Asia and certain areas of Latin America. 
Figure 15 summarizes the lifecycle of the three main African trypanosome species. The parasites 
are ingested by tsetse flies when they feed on the blood of infected animals. They undergo a 
cycle of development in various locations within the fly depending on the trypanosome species. 
All three species finish this phase of their development as metacyclic forms in the tsetse mouth 
parts or salivary glands. 
 
Figure 15. Life cycle of T b brucei, T congolense and T vivax. Heavy outlines indicate parasite 
forms with surface coats consisting of variable glycoprotein antigens. Light outlines indicate 
uncoated forms which are not infective to mammals. T b brucei develops in the tsetse midgut, 
proventriculus and salivary glands, where metacyclic forms occur which are infective to 
mammals. T congolense develops in the tsetse midgut, proventriculus and mouth parts, where 
infective metacyclic forms are produced. T vivax develops in the tsetse mouthparts. 
The metacyclic trypanosomes are transmitted into an animal's skin when an infected tsetse feeds. 
In the case of T b brucei and T congolense, a prominent swelling, called a chancre, develops at 
the site where the parasites are introduced. The trypanosomes develop in the chancre: in T 
congolense infections a local reaction form can be distinguished at this stage. The parasites then 
invade the local lymph vessels and move into the bloodstream where they undergo further 
development. The infection which follows is characterized by successive waves of parasitaemia, 
as parasite populations multiply rapidly and die off. T vivax and T b brucei parasites may also 
invade the connective tissues, and, in later stages of the disease, T b brucei may be found in the 
central nervous system. In the human disease, African sleeping sickness, T b rhodesiense or T b 
gambiense parasites invade the central nervous system, causing death. 
Trypanosomiasis in livestock causes anaemia, poor growth, infertility, and abortion. Many 
infected animals die. Others may eventually eliminate the parasites and recover, but their growth 
and productivity are often reduced. 
At present, trypanosomiasis is controlled primarily by spraying tsetse resting and breeding sites 
with insecticide and by treating livestock regularly with trypanocidal drugs. However, neither of 
these approaches is completely effective in areas of heavy infestation. Further problems include 
the repeated use of the few drugs available, which may lead to drug resistance, and the 
possibility of environmental pollution due to large-scale insecticide spraying. 
The goal of ILRAD's trypanosomiasis program is to develop effective, safe and economic 
methods to control the disease. This could be by immunological, chemical or genetic means. 
Research concentrates on the development of control measures which interfere with the parasites 
themselves or improve the responses of infected animals. Scientists are also studying aspects of 
trypanosomiasis epidemiology at a field site near the Kenya coast and in a collaborative animal 
production research network at sites in several African countries. 
Towards improved control of the parasites 
In the course of an infection, successive generations of trypanosomes display different antigens 
on their surface coats. These antigens are variable surface glycoproteins (VSGs). Trypanosomes 
with different VSGs are called variable antigen types (VATs). Trypanosomes in the tsetse fly are 
not coated with variable antigens until they develop into the metacyclic forms which are 
transmitted to mammals. Metacyclic trypanosomes are thought to display a limited number of 
VSGs, while the parasites which develop in the bloodstream may display very large numbers, 
thus evading the immune responses of the host. 
In 1982, research on trypanosomes concentrated on the genetic basis of antigenic variation and 
on the structure and synthesis of the variable antigens. Other studies focused on the identification 
of specific variable antigens and on their role in the course of infection. Techniques developed 
earlier to cultivate and maintain trypanosomes in vitro were extended as progress continued 
towards the goal of maintaining all three major trypanosome species on a continuous basis. This 
technology has made it possible to study the different stages of the trypanosome lifecycle in 
detail as well as the mechanisms involved in the transition from one stage to the next. The goal 
of all these projects is to identify factors which could be manipulated to disrupt parasite 
development. 
Antigenic variation: the genetic basis 
Antigenic variation involves switching on and off the expression of a large family of genes 
which code for different VSGs. Molecular biologists at ILRAD are studying the changes which 
occur when different genes are expressed. This work is being carried out in collaboration with 
Cambridge University's Molteno Institute, the Université Libre de Bruxelles and the Vrije 
Universiteit Brussel. 
The expression of different VSGs during the course of infection is associated with 
rearrangements in the parasite DNA. Two types of gene rearrangement have been observed in T 
b brucei. Sometimes the expression of a VSG gene is accompanied by the appearance of a 
duplicated copy of the gene at a new location in the genome. The extra copy disappears when the 
gene is no longer expressed. This type of rearrangement has been termed 'expression-linked 
duplication'. When scientists at ILRAD cloned parasites from one T b brucei stock at different 
times, they also found three different VSG genes which were not duplicated when their antigens 
were expressed. This indicates that a second type of gene rearrangement can occur in association 
with antigenic variation. The different type of gene rearrangement is related to the specific VSG 
gene being expressed, not to general differences between typanosome stocks. 
Scientists have been studying four VSG genes from the ILTaR 1 antigen repertoire. Of these, 
only one (ILTat 1.1) undergoes rearrangement involving expression-linked duplication. There 
are four distinct copies of the ILTat 1.3 gene and three of the ILTat 1.4 gene in each member of a 
closely related group of trypanosome clones, and the number of copies of these genes does not 
vary with expression. One copy of the ILTat 1.3 gene has been characterized in detail and 
compared with known ILTat 1.3 messenger RNA. Beyond a homologous region, the two 
sequences differ completely, indicating that this copy gene cannot code for a normal VSG. 
Rearrangements have been detected in the genomic environment of some, but not all, copies of 
these two genes. For those copies which do undergo rearrangement, ILRAD scientists have 
found that clusters of enzymes cut the DNA at a site which is probably at the end of a 
chromosome. Figure 16 shows eight restriction enzyme fragments of DNA during a period of 
treatment with the enzyme Bal 31 exonuclease. Two fragments (12.0 and 7.2 kilobases) have 
been digested by the enzyme, while the others have not. This indicates a natural double-strand 
break in the DNA at this site. 
`  
Figure 16. Bal 31 digestion of T b brucei nuclear DNA: 40 µg of DNA was digested with 13 
units of Bal 31 enzyme in 600 mM NaCl, 12mM CaCl2,, 12 mM MgCl2, 20 mM Tris-HC1 pH 8 
and 1 mM EDTA. The reaction was incubated at 30°C and aliquots were taken at times shown by 
pipetting into water-saturated phenol. Each DNA was precipitated with ethanol and 
subsequently digested with Aval restriction endonuclease. The digested DNAs were 
electrophoresed in a 0.8% agarose gel and transferred to nitrocellulose paper. The plasmid 
pcBC1 containing the complete coding sequence for VSG ILTat 1.3 was nick-translated and 
hybridized. The figure shows the results of the blotting experiments: only fragments 12.0 and 7.2 
kilobases were digested by the enzyme. 
Thus two copies of the ILTat 1.3 gene are both adjacent to the end of a DNA molcule. These 
copies might be located on unusual extra chromosomal DNA structures. To test this possibility, 
DNA was prepared from three trypanosome clones expressing VSGs ILTat 1.2, 1.3 and 1.4 and 
fractionated on sucrose density gradients. Figure 17 shows the distribution of the four copies of 
the ILTat 1.3 gene in one of the gradients. Copy D is located on fractions 16 and 17 and has been 
clearly separated from the bulk of the nuclear DNA. It appears that this copy is located on a 
minichromosome—a DNA molecule that is separate from, and smaller than, the bulk of the 
trypanosome DNA. This small molecule is present whether the ILTat 1.3 gene is expressed or 
not. It may be some form of intermediary in the normal nuclear gene rearrangement associated 
with antigenic variation. 
 
Figure 17. Location of ILTat 1.3 genes in fractions from intact trypanosome DNA sedimented 
through a sucrose density gradient. Trypanosomes homogeneously expressing different VSGs 
were isolated by Percoll density gradient centrifugation. The trypanosomes were lysed by adding 
SDS to 0.5%. The lysate was incubated for 2 h with 100 mg ml–1 RNase A (previously heated to 
70°C for 60 min), then for 4 h with 1 ml–1 of Pronase (preincubated at 37°C for 2 h), both at 
37°C. The extremely viscous DNA solution was layered onto a 10–40% sucrose gradient in 10 
mM HCI, 5mM EDTA pH 8.0 and centrifuged at 24 000 rpm for 10 h. The gradient was 
fractioned with an ISCO gradient fractionator (30 × 1.2 ml fractions). The position of the ILTat 
1.3 genes in the gradient was determined by a Southern blot analysis of DNA from alternate 
fractions digested with Hincll, using pcBC1 as a probe. Tracks marked × are digests of 
unfractionated DNA. A, D, B and C mark the Hincil fragments from the four distinct copies of 
the ILTat 1.3 gene. Copy D is purified at fraction 16, while the other copies are purified at 
fraction 30. This shows that copy D is smaller and can be separated from the others. 
Antigenic variation: synthesis and maintenance of the surface antigens 
The surface antigen coat is probably the only component found in common on all African 
trypanosomes. The integrity of this structure is crucially important to the survival of the parasites 
in the host bloodstream. For this reason, biochemists at ILRAD are investigating how the VSGs 
are synthesized in the parasite and exported to the cell surface. A thorough knowledge of this 
process may suggest some form of interference which will disrupt the stability of the surface coat 
and render the trypanosome susceptible to host defence mechanisms. 
Previous work at ILRAD and elsewhere has shown that T b brucei and T congolense VSGs 
contain two different types of carbohydrate (CHO) side chains, added to the protein by a process 
called glycosylation. The first is constructed in a region of the parasite cell called the 
endoplasmic reticulum (ER) shown in the simplified diagram of a trypanosome (Figure 18). It is 
attached to the protein by a linkage found in mammalian and other systems, and its addition can 
be blocked by the antibiotic tunicamycin. The other CHO side chain is linked near the end (C-
terminal) of the protein by a mechanism which has not yet been described in any system and 
which cannot be blocked by tunicamycin. Its importance is suggested by evidence that it remains 
constant for all VSGs of T b brucei and T congolense. 
 
Figure 18. Bloodstream form of T congolense. Derived from K Vickerman, 1969, Journal of 
Protozoology, 16: 56. 
  
 
Figure 19. Electron micrograph of T vivax rough endoplasmic reticulum (a), smooth 
endopiasmic reticulum (b) and Golgi (c). Endoplasmic reticulum and Golgi fractions were 
isolated from total microsomes obtained from T b brucei, T congolense and T vivax and tested 
for glycosyltransferase activities. Trypanosomes were disrupted in 250 mM sucrose-HKMM (50 
mM HEPES, 25 mM KCI, 5 mM MgSO4, 10 M MnC12; pH 7.4 at 5°C). Crude microsomes were 
prepared and a Golgi fraction isolated essentially after the method of Redman et al, 1975 
(Journal of Cell Biology, 66: 42). Both smooth and rough endoplasmic reticulum fractions were 
prepared from the residual microsomal fractions according to the method of Ragland et al, 1971 
(Biochemical Journal, 121: 271). 
 Figure 19(b). 
It is more difficult to purify VSG from T vivax than from T b brucei or T congolense using 
available methods. However, ILRAD scientists have recently purified a VSG-like protein from a 
T vivax clone and are now conducting studies to determine how this molecule(s) compares 
biochemically and immunologically with VSG isolated from the other trypanosome species. 
The synthesis of trypanosome VSG involves three subcellular organelles: the protein molecules 
are first synthesized on the rough ER and are then transported by the smooth ER to the Golgi 
apparatus. The CHO side chains are added during this process. The function of the side chains is 
unknown, but they may play a role in bringing the glycoprotein to the membrane surface. They 
may also enable the Golgi apparatus to recognize the VSG. This is important because the Golgi 
processes and sends glycoproteins to a variety of other cellular locations. 
In 1982, ILRAD biochemists purified fractions of Golgi and rough and smooth ER in order to 
identify which of these subcellular organelles is critical to the synthesis of the VSG. This work 
was carried out in collaboration with Harvard University. 
Golgi and ER fractions were isolated from T b brucei T congolense and T vivax and checked for 
morphological purity by electron microscope examination. Figure 19(a) is an electron 
micrograph of a rough ER fraction from T vivax, showing spherical and flattened vesicles with 
irregularly arranged attached ribosomes. Clusters of free ribosomes, fragmented microtubules 
and other non-membrane material are also present. As shown in Figure 19(b), the smooth ER 
fractions from T vivax consist primarily of clear granular vesicles 30–200 nm in diameter. A few 
vesicles contain some flocculent material, but vesicles with attached granules are rare. All T 
vivax Golgi fractions contain flattened u-shaped, curved or cup-shaped cisternae with slightly 
expanded rims, as shown in Figure 19(c). 
 
Figure 19(c). 
The different glycosyltransferase enzymes involved in the process of glycosylation are being 
characterized biochemically. From total preparations of T b brucei, galactosyltransferase, 
mannosyltransferase and two different N-acetylglucosaminyltransferases have been 
characterized. Studies are now in progress to clarify the possible role of sialyl- and fucosyl-
transferases using the purified ER and Golgi fractions. The glycosyltransferase activities 
observed so far have been remarkably similar in all fractions of the three major trypanosome 
species. The Golgi fractions contain the majority of the galactosyltransferase activity, followed 
by the smooth and then the rough ER. The dolicholdependent mannosyltransferase activity was 
highest for rough ER, then for smooth ER and then for Golgi. 
The dolichol-independent N-acetylglucosaminyltransferase activity was similar in all the 
fractions tested, while the dolichol-dependent N-acetylgluco-saminyl- transferase activity was 
much higher for ER than for Golgi, and somewhat higher for smooth than for rough ER. This 
enzyme is sensitive to tunicamycin inhibition in smooth ER, but not in rough ER or in Golgi, 
which suggests that it may take two or more forms. It also suggests that the core carbohydrate 
may be added to the VSG in the smooth ER. Experiments are currently in progress to see if these 
membrane fractions can process a mature VSG in vitro. 
Another perspective on the factors involved in the synthesis and maintenance of trypanosome 
VSGs is provided by the stage of development when VSG synthesis stops. This occurs when 
bloodstream trypanosomes change into uncoated forms in the midgut of the tsetse fly. A culture 
system is available in which an entire population of bloodstream trypanosomes can be induced to 
transform into the fly midgut stage in 2 days. The termination of VSG synthesis is being 
investigated by incorporating radioactive amino acids into newly synthesized protein and looking 
for rearrangements of the genes encoding for VSG by gene probe hybridization to Southern 
blots. This method is being used to analyse trypanosomes in the process of shutting off VSG 
synthesis, as well as trypanosomes many generations after VSG synthesis has ceased. 
Cultivation of trypanosomes in vitro 
Cell biologists at ILRAD have made steady progress in the development of techniques to 
propagate the various stages of T b brucei, T congolense and T vivax in vitro. In collaboration 
with other scientists, these techniques have been used to study the biological, biochemical and 
immunological properties of the parasites. A great deal of trypanosomiasis research is now 
possible which could not be carried out in the past when trypanosomes could only be maintained 
by continuous passage through tsetse vectors and mammalian hosts. 
Beginning with T b brucei, techniques have been developed to propagate and maintain 
trypanosomes in cell culture throughout all the stages of their life cycle (see Figure 20). Recent 
work has focused on extending these techniques to the cultivation of T congolense and T vivax. 
Once a system for maintaining trypanosomes is proven successful on an experimental basis, it 
can be standardized and used to produce large numbers of parasites which are required for many 
different research projects. 
   T b brucei T congolense T vivax 
Bloodstream forms (coated 
trypomastigotes) 
yes up to 35 days up to 7 days 
Procyclic forms (uncoated 
trypomastigotes) 
yes yes yes 
Epimastigotes Yes yes yes 
Metacyclics Yes yes no 
Complete lifecycle on 
continuous basis 
Yes no no 
Figure 20. Stages of trypanosome development which can now be maintained in vitro. 
Using the culture system established for T b brucei, two simple in vitro tests were developed in 
1982 to screen the effectiveness of trypanocidal compounds. The trypanocidal activity of a 
compound can be expressed in terms of the minimum drug concentration required to inhibit 
trypanosome growth by significantly more than 50% during 24 hours' exposure. Nine 
compounds were screened in 1982, with results shown in Figure 21. The tests being developed 
also measure any toxic side-effects on the bovine feeder cells included in the culture system. 
These two drug-screening procedures are now being applied to T b brucei field isolates. Tests are 
also being developed to screen the effectiveness of trypanocidal drugs against T congolense and 
T vivax. This work is carried out in collaboration with the Kenya Trypanosomiasis Research 
Institute and the Gesellschaft für Technische Zusammenarbeit (GTZ) of the Federal Republic of 
Germany. 
Compound (trade name) Supplier 
MIC50 
(g/ml) 
Diminazene aceturate (Berenil) Farbwerke Hoechst 1.00 
Isometamidium (Samorin) May 8 Baker 10.00 
Phenanthridinium bromide (Novidium) Boots 3.00 
Quinapyramine dimethylsulfate (Antrycide) Imperial Chemical 0.10 
Melarsporol B.P. (Arsobal) La Specia 0.01 
Suramin (Naganol) Bayer 1.00 
α-difluoromethylornithine Merrell-Dow 300.00 
4', 6-diamidino-2-phenylindole Serva 1.00 
Quinapyramine isethionate May & Baker 1.00 
Figure 21. Minimum inhibitory drug concentration (MIC50) required to inhibit in vitro growth of 
T b brucei bloodstream forms by significantly more than 50% during 24 h exposure. 
The method of propagating T congolense metacyclics in vitro has been simplified and improved. 
Cultures are now initiated with bloodstream forms taken from infected rodents and raised in the 
presence of purified bovine dermal collagen. Six populations of T congolense parasites are 
maintained on a continuous basis, four from clones and two derived from uncloned stocks. 
Work with T vivax has concentrated on two stages of parasite development: the surface-coated 
trypomastigote which develops in the bloodstream and the uncoated trypomastigote which is 
presumably equivalent to the next stage of development after the trypanosome is ingested by a 
tsetse fly. A culture system was tested in 1982 which maintains the coated bloodstream form for 
several days and a new system was developed in which coated parasites are induced to change to 
the uncoated form. 
. 
Confirming results of previous research, bloodstream forms of a West African T vivax stock 
(Zaria Y 486 derivative) were isolated from a goat and maintained in vitro in collaboration with 
the Swiss Tropical Institute. The parasites multiplied in culture and showed the T vivax 
bloodstream-form morphology. Best results were obtained when Microtus montanus (mountain 
vole) whole embryo fibroblasts were used as the feeder layer. A similar effort to propagate two 
East African T vivax stocks (ILRAD 1875 and KETRI 2377) in culture has not yet been 
successful. 
Bloodstream trypomastigotes from the West African T vivax stock can now be taken from 
infected mice, maintained in culture and induced to change to the uncoated form. After being 
kept at 25°C for 3 days, the parasites are no longer infective to mice; examination with the 
electron microscope reveals that they lack a surface coat. Using this method, 109 or more of the 
uncoated forms can be produced at a time. 
Several interesting findings have resulted from this work. For one thing, scientists at ILRAD 
have now observed rapidly dividing short-slender forms of T vivax with the kinetoplast at the 
posterior end during periods when parasite populations are rising (see Figure 22) and non-
dividing elongated-slender forms with the kinetoplast midway between the posterior end and the 
nucleus during periods of peak parasitaemia (see Figure 23). Short tadpole-like forms have also 
been observed which are possibly senescent. These can also be seen in Figure 23. This 
pleomorphism is more pronounced when T vivax is raised in mouse blood than in goat or cattle 
blood. In vitro experiments have shown that the short-slender forms are more easily maintained 
in culture than the elongated-slender forms. However, the elongated forms change more readily 
in culture into the uncoated stage. 
 
Figure 22. Bloodstream forms of T vivax (ILRAD 1392) during rising parasitaemia in a mouse. 
There are many dividing forms (D). Note the position of the kinetoplast, indicated by the arrows, 
at the posterior end 
 
Figure 23. Bloodstream forms of T vivax (ILRAD 1392) in a mouse at the peak of parasitaemia. 
Note the pleomorphism: some parasites are elongated (L) with the kinetoplast midway between 
the nucleus and the posterior end, while others are shorter (S), with the kinetoplast at the 
posterior end, or tadpole-shaped (T). 
 Figure 24. Uncoated forms of T vivax (ILRAD 1392) transformed from the bloodstream form at 
25°C in vitro. Under these conditions, they attach to the surface of matrix Green Gel A beads 
(Amicon) within 3 days. These parasites are noninfective to mammalian hosts. 
When uncoated T vivax trypomastigotes were cultured with Matrex Green Gel A beads 
(Amicon), many of them became attached to the beads at their anterior end, as shown in Figure 
24. These parasites probably attach themselves in a similar way to the mouth parts of tsetse flies. 
Uncoated forms of other trypanosome species do not become attached to the gel beads in culture, 
so this difference in behaviour might be used to identify T vivax in vitro. When uncoated T vivax 
trypomastigotes transform further to the shorter epimastigote forms, those parasites which were 
attached to beads survive longer than those which were not. The T vivax culture system is now 
being developed further in an effort to support transformation to the metacyclic stage and back to 
the bloodstream form, thus completing the parasite lifecycle. 
Work was initiated in 1982 on the biochemical characterization of forms of T vivax, T 
congolense and T b brucei propagated in vitro. This work has been undertaken in collaboration 
with a visiting scientist from the University of Ibadan in Nigeria. 
Detailed studies of the parasite lifecycle 
Metacyclic forms of T b brucei are injected in the bite of an infected tsetse fly, and change to 
long-slender forms which multiply rapidly in the mammalian bloodstream. Many of the long-
slender parasites differentiate into intermediate and then short-stumpy forms which do not 
multiply and eventually die out. The parasite population usually rises and falls in a series of 
waves associated with this rapid multiplication and differentiation to the senescent form. 
It has been postulated that a similar differentiation from a rapidly dividing to a non-dividing 
bloodstream form occurs in T congolense and T vivax, though the physical changes are less 
obvious. Significant evidence was obtained in 1982 that such a differentiation does occur in 
these two trypanosome species, indicating that this is an important phenomenon which might 
present a target for disease control. 
Different stages in the parasite lifecycle are characterized by different DNA contents. Non-
dividing cells contain a baseline amount of DNA, while in an actively dividing population many 
cells have double the baseline DNA content in preparation for cell division. Using ILRAD's 
fluorescence-activated cell sorter, two actively dividing forms of T b brucei, procyclic forms 
equivalent to those which develop in the tsetse midgut and long-slender bloodstream forms, were 
shown to contain more DNA than non-dividing metacyclic and short-stumpy bloodstream forms. 
An analysis of early and late T vivax bloodstream populations revealed a similar transition from a 
dividing state to a non-dividing state with less DNA. This analysis is now being extended to T 
congolense. 
Other studies focus on the proteins which are specific to different stages of the T b brucei 
lifecycle. The aim is to identify proteins which could serve as targets for immunological or 
chemotherapeutic attack. In 1982, proteins were examined which are specific to the long-slender 
and short-stumpy bloodstream forms and to the uncoated procyclic form. The protein 
composition of whole parasites at these different stages was analysed using two-dimensional gel 
electrophoresis. Several differences appeared, but the background of thousands of unchanging 
proteins made it difficult to detect which changes were significant. For this reason, the nuclei of 
trypanosomes in the three stages are being purified and analysed using the same procedure. 
Many physiological processes similar to trypanosome differentiation are mediated through the 
action of a limited set of structurally related regulatory proteins which depend on calcium. 
Recently, ILRAD scientists detected one of these, calmodulin (CaM), in T vivax. This protein is 
now being purified and analysed biochemically. Preliminary evidence suggests that it is smaller 
than vertebrate CaM. Scientists elsewhere have found that CaM isolated from T b brucei is also 
smaller than vertebrate CaM. In addition, CaM-like activities in T b brucei, T congolense and T 
vivax do not cross react well with mammalian CaM when tested by radioimmunoassay. These 
are important findings because if CaM in fact plays a role in the differentiation process and if 
trypanosome CaM differs biochemically from the mammalian protein, then it may be possible to 
treat animals to inhibit this molecule and disrupt the parasite lifecycle without interfering with 
the host. 
Trypanosome respiration and energy production systems have also been shown to change at 
different stages of the parasite lifecycle. Procyclic trypanosomes possess a fully functional 
mitochondrion and their respiration depends in part on the conventional cylochrome electron 
transport system. Bloodstream forms, however, appear to lack cytochromes; their energy is 
produced by glycolysis using an L-glycerophosphate oxidase (GPO) transport system. Studies in 
vitro have shown that respiration depends entirely on the -GPO system in bloodstream forms of 
T b brucei, T congolense and T vivax. The respiration of T b brucei procyclics raised in vitro 
depends in part (35%) on the cytochrome electron transport system and in part (65%) on the -
GPO system.. For T congolense procyclics, 25% of respiration depends on the cytochrome 
system and 75% on the -GPO system, while respiration of T vivax procyclics raised in vitro for 4 
days depends entirely on the -GPO system. 
Towards Improved Host Responses 
Several studies at ILRAD focus on the complex interactions between trypanosomes and their 
hosts. Research concentrates on factors which affect host antibody production and on other host 
responses which play a role in resistance to the parasites. A better understanding of these 
interactions could lead to several possibilities for improved disease control. 
Immune Responses 
When mice are infected with T b brucei, they produce specific antibodies directed against 
parasite VSGs, as well as a variety of unrelated antibodies. These antibodies are produced by one 
type of lymphoid cell, the B-cell. B-cells are stimulated to multiply soon after infection. This 
occurs well before antibodies are produced, particularly in susceptible mouse strains. 
In 1982, five mouse strains were infected with a T vivax stabilate derived from West Africa. All 
mice of the most susceptible strain died within 10 days of infection, while none of the most 
resistant strain died within 10 days and 50% were still alive after 40 days. Specific immune 
responses were analysed using the immune lysis test. The most susceptible mouse strain 
produced no antibodies either specific to the parasite or non-specific, while the most resistant 
strain produced both specific and non-specific antibodies. Further experimentation showed that 
the susceptible mice were in fact capable of responding to parasite antigens. Spleen cells taken 
from the susceptible mice were analysed using the fluorescence-activated cell sorter, and their B 
cells were found to be dividing. Thus these cells, while stimulated to divide, are apparently 
inhibited from completing the final stages of differentiation into antibody secreting cells. 
Studies in livestock have shown that immune responses to metacyclic trypanosomes are highly 
specific for particular parasite populations. When cattle or goats are infected by tsetse with 
metacyclic forms of T congolense or T b brucei and treated at least 15 days later with 
trypanocidal drugs, they resist rechallenge with the same trypanosome stock but are fully 
susceptible to challenge with different stocks of the same species. In 1982, further experiments 
were carried out to determine whether cattle would develop a similar resistance based on 
infection by intradermal inoculation, using metacyclic trypanosomes propagated in vitro. Cattle 
were infected in this way with metacyclic forms of T congolense. They were treated 60 days later 
with the trypanocidal drug diminazene aceturate (Berenil-Farbwerke Hoechst AG). Ninety days 
after treatment, they were challenged by inoculation with the same T congolense stock and were 
immune to reinfection. 
Research was also carried out in 1982 to isolate and characterize the specific parasite VATs 
responsible for recurrent peaks of host antibody production. Three steers were infected with a T 
congolense stock (ILNat 3.1) and two steers with a stock of T b brucei (MITat 1.2). Blood 
samples were taken every day and examined for the presence of infecting VATs using the IFA 
test. A reappearing T b brucei VAT has been identified and is now being cloned for further 
study. 
When animals infected with trypanosomes are presented with unrelated antigens, they produce 
lower levels of specific antibody than uninfected animals, or none at all. In many cases, the 
capacity of infected animals to respond to trypanosome VSGs is also reduced. This depression of 
the immune response is more marked in infected animals which are susceptible to 
trypanosomiasis than in infected animals which are more resistant. Experiments in 1982 showed 
that spleen cells taken from mice infected with T vivax or T b brucei produce considerably more 
prostaglandin hormones than spleen cells of uninfected mice. The concentration of 
prostaglandins produced by spleen cells taken from infected mice reaches levels which other 
investigators have shown are sufficient to reduce the immune response in living animals. Among 
infected mice, spleen cells from more susceptible strains often produce more prostaglandins than 
spleen cells from resistant strains. The addition to the spleen cell cultures of trypanosomes which 
were coated with antibodies or killed by freezing and thawing dramatically increases the amount 
of prostaglandins produced, especially when the spleen cells are from infected mice. These 
findings suggest that prostaglandin synthesis in animals infected with trypanosomes may 
contribute to the depression of the immune response. 
The results of this study also suggest that dead or antibody-coated trypanosomes provide the 
fatty acid precursor for prostaglandin synthesis or provide an enzyme, such as phospholipase A2, 
which makes fatty acids available. If this is the case, the degree of immunodepression in an 
infected animal may be related to the number of parasites which multiply and die in the 
bloodstream. Further work concentrates on identifying the type of spleen cell which produces 
prostaglandins and the role of these cells in regulating parasitaemia and the immune response.  
Other host responses 
Host capacity to control parasite growth rates appears to be a key factor in resistance to 
trypanosomiasis. Scientists at ILRAD are studying host reactions which may limit trypanosome 
growth and development in the skin at the site of an infected tsetse bite, in the lymphatic system, 
and in the bloodstream. Studies also cover responses in the central nervous system at later stages 
of infection. 
The local skin reaction 
The chancre which develops in the skin at the site of an infected tsetse bite represents the host's 
first response to the parasite. When resistant wild animals are bitten by infected tsetse flies, they 
develop much smaller chancres than susceptible livestock. The prepatent period is also much 
longer before parasites can be detected in the blood. This suggests that the resistance of wild 
species is related to a capacity to control the parasites in the skin before they reach the 
bloodstream. Investigations at ILRAD concentrate on the possible role of the local skin reaction 
in conferring resistance, in particular on the structural changes and the distribution of parasites in 
the chancre and on the specific parasite material which induces the skin response. This work may 
indicate how parasite proliferation is controlled in the skin and may provide markers for genetic 
resistance. 
In one study, cattle were challenged by tsetse flies infected with T congolense. Skin biopsies and 
blood were collected at regular intervals and anaemia and parasitaemia were monitored. The 
biochemical analysis of tissue taken from the chancres revealed a variety of proteins and peptides 
(see Figure 25). Some of these have been shown to be aminopeptidases, while others are as yet 
only partially characterized. It is not yet clear whether these chancre-associated proteins and 
peptides are of host or parasite origin. The next step will be to characterize chancre-associated 
proteins, peptides and other molecules from animals which are resistant to trypanosomiasis. 
 Figure 25. Reverse phase high performance liquid chromatographic (HPLC) analysis of bovine 
chancre-associated peptides. This chromatogram shows the resolution of 80% ethanol-soluble 
peptides and other small molecules obtained from chancre extracts taken on days 0, 7, 10 and 14 
after cattle were challenged by tsetse infected with T congolense. The study reveals a 
progressive appearance of molecules with retention times (Rt) between 3.8 and 5.33 minutes, 
reaching a 50-fold increase on day 10. Two other major chancre-associated peptides with 
approximate Rts of 7.0 and 9.6 minutes show increases of 14- and 6-fold respectively. 
In a related study carried out in collaboration with the Swiss Tropical Institute, goats and cattle 
were challenged by tsetse flies infected with the three major trypanosome species, and biopsies 
were taken of chancres at intervals after infection. Chancre formation in these animals will be 
compared with skin reactions produced in infected buffalo. 
Goats were also inoculated intradermally with bloodstream forms of T vivax, T b brucei and T 
congolense. Using this method, it was possible to measure how many trypanosomes were 
injected in the skin and to rule out the effects of tsetse saliva. With T vivax and T b brucei, a skin 
reaction was produced which appeared identical to a chancre. The onset, size and duration of the 
skin reaction depended on the number of trypanosomes inoculated: as few as 102 T b brucei 
parasites were sufficient to produce a chancre, whereas 104 T vivax were required. With T 
congolense, no chancre developed even when 107 bloodstream parasites were inoculated. . 
When an animal is bitten by an infected tsetse fly, uncoated procyclic trypanosomes may be 
injected into the skin along with the metacyclic forms. To test the possible role of procyclic 
trypanosomes in stimulating chancre formation, goats were inoculated intradermal with procyclic 
parasites. When 108 T b brucei or T congolense procyclics were inoculated, an intense 
inflammatory reaction was detectable during the first 3 to 4 days. Smaller numbers of parasites 
did not produce a reaction. 
Another study is in progress to determine what parasite material stimulates the skin reaction. T 
congolense metacyclics have been collected from tsetse flies and placed in millipore diffusion 
chambers. Chambers with a pore size of 0.45. µm have been implanted under the skin of goats. A 
definite skin reaction occurs, similar to, but smaller than a chancre, despite the fact that the 
trypanosomes are unable to exit from the chamber and initiate infection. 
The role of the lymphatic system 
Trypanosome have been observed in lymphatic vessels in the region of the chancre and in 
enlarged lymph nodes draining the site of infected tsetse bites. In 1982, investigations continued 
on the role of the lymphatic system in the development of trypanosome infections. 
Calves were challenged by tsetse infected with T congolense and the lymph nodes draining the 
resulting chancres were cannulated. Lymph flow was measured and the cellular and parasite 
content of the lymph was monitored. Trypanosomes were detected in efferent lymph 3 to 5 days 
before they were observed in the bloodstream, as shown in Figure 26. Antibodies specific to the 
infecting parasite clone were detected in both lymph and plasma 2 weeks after infection. Further 
work will concentrate on typing lymphatic cells in the chancre, the efferent lymph and the 
bloodstream and identifying which cell types respond to trypanosome antigen. 
 Figure 26. Parasitaemia in the lymph and blood of calves infected with T congolense. 
Trypanosomes were always detected earlier in lymph than in blood, but the peak levels of 
parasitaemia were 1 to 2 logs higher in the bloodstream. 
Control of parasites in the bloodstream 
For T b brucei and possibly for other trypanosome species, the level and duration of parasitaemic 
waves in the bloodstream appear to be related to parasite differentiation from an actively 
dividing to a non-dividing form. Earlier research has shown that some factor in the host plays a 
role in the timing of parasite differentiation and thus in the level of parasitaemia, because 
differentiation occurs at different times in different host species and strains, even when the 
parasite population is genetically identical. 
The pattern of host resistance to T b brucei has been studied in detail in mouse strains which are 
relatively resistant or susceptible to trypanosomiasis. Trypanosome populations rise to a peak in 
the bloodstream as long-slender parasites divide. The level and duration of these parasitaemic 
peaks appears to depend on the timing of differentiation from rapidly dividing, long-slender 
parasites to the senescent short-stumpy forms. Studies in 1982 confirmed that trypanosome 
differentiation is slower in susceptible mouse strains. This slower differentiation is accompanied 
by a delayed host antibody response, but rapid parasite differentiation in resistant mice does not 
appear to be due to more efficient antibody production. Rather, host antibody responses seem 
only to be effective against the parasites after a number of short stumpy forms have appeared and 
the expansion of the trypanosome population has already slowed down substantially. 
Clearance studies with 75Se-methionine labeled trypanosomes and adoptive transfer experiments 
have shown that antibodies produced against specific parasite VSGs do not destroy either long-
slender or short-stumpy T b brucei parasites selectively, nor do they stimulate the parasites to 
differentiate to the short-stumpy form. Furthermore, parasite growth and differentiation rates 
were found to be the same in irradiated mice with or without reconstituted spleen cells, although 
antibody was detected in the spleen-cell-reconstituted mice and not in the others. This indicates 
that control of parasitaemia is not entirely dependent on the production of antibodies. 
The development of T b brucei infections has also been compared in relatively susceptible 1-
week-old calves and more resistant yearlings. As in mice, this study showed that resistance in 
cattle is apparently related to the ability to control parasite growth rates in the bloodstream and 
this in turn is related to the timing of parasite differentiation. 
When mice were treated with Corynebacterium parvum, an adjuvant which enhances resistance 
to trypanosomiasis, and infected 4 days later with T b brucei, parasite differentiation occurred 
earlier than in controls. During the first 9 days after infection, peaks of parasitaemia were lower 
and of shorter duration in the treated mice, as illustrated in Figure 27. No difference was found in 
antibody production between the treated mice and the controls during the first 7 days after 
infection, which indicates that some other response was involved in the control of parasitaemia. 
The factors which regulated parasite growth and differentiation were partly radio-insensitive. 
 Figure 27. When C57B1/6 mice were treated with C parvum 4 days before challenge with T b 
brucei, the subsequent level of parasitaemia was significantly reduced. 
Resistance to trypanosomiasis, as measured by survival, appears to be an inherited trait involving 
several genes. Specific host responses which contribute to resistance may be under less complex 
genetic control. To investigate this possibility, the genetic bases of factors regulating the growth 
of T vivax and T b brucei in the bloodstream were compared in susceptible and resistant mice. 
Random matings were established between a susceptible and resistant strain, and offspring were 
tested for their capacity to control parasitaemia. F1 crosses were then crossed with Fl s and bred 
back to both the parental strains. The results indicate that control of parasitaemia is based on a 
co-dominant gene system which is possibly fully as complex as the genetic basis of resistance 
measured in terms of survival. 
To test the effects of host products on trypanosome survival, growth and differentiation rates, T b 
brucei parasites at different stages of development were maintained in a cell- and serum-free 
culture medium and exposed to a variety of substances they might encounter in the mammalian 
bloodstream. Without any additions to the medium, long-slender forms survived for 40 hours: 
during the first 5 hours they retained 100% infectivity for mice, from the 5th to the 20th hour 
they showed progressively less infectivity, and from the 20th to the 40th hour they developed 
into stumpy-like forms which were not infective for mice but were viable and had a surface coat. 
When moved to appropriate culture conditions, they differentiated to procyclic-like forms, 
showing that they were not irreversibly committed to degeneration. Intermediate parasite forms 
survived for 20 hours in culture and underwent changes similar to those occurring in the long-
slender forms in their last 20 hours of culture. Short-stumpy parasites survived in culture for 4 to 
5 hours, undergoing changes similar to those occurring during the last 10 hours of culture of the 
long-slender and intermediate forms. 
The addition of transferrin, bovine serum albumin, foetal bovine serum, normal mouse plasma or 
normal mouse serum to the cultures all extended the life-span of the parasites, but had no effect 
on declining infectivity. Thirteen other substances were tested, including prostaglandins, insulin 
and epidermal growth factor, but these had no effect on parasite viability or infectivity for mice. 
Spleen cells from normal or trypanosome-infected mice extended the parasite life-span, 
stimulated the parasites to multiply and slowed down their loss of infectivity. These effects were 
more pronounced when spleen cells were taken from relatively susceptible mouse strains than 
from resistant strains, while spleen cells from mice of intermediate susceptibility were 
intermediate in terms of their capacity to extend parasite survival and infectivity. 
In a related study, actively dividing T congolense parasites were cultured in vitro with cells taken 
from resistant and susceptible strains of mice. Subpopulations of mouse spleen cells and 
peritoneal exudate cells were used. As in the previous study, the trypanosomes survived less well 
when cultured with cells from relatively resistant mice. Trypanosome viability was also lower 
when the parasites were cultured with cells taken from mice previously injected with C parvum, 
as shown for the peritoneal exudate population in Figure 28. When trypanosomes were cultured 
with cells taken from cattle or buffalo, the results also reflected relative susceptibilities in vivo: T 
b brucei parasites survived equally well when cultured with cattle or buffalo cells, but T 
congolense cultured with buffalo cells did not survive well. These systems are now being used 
for a detailed investigation of the mechanisms involved in host resistance to trypanosomiasis and 
may be useful in screening to identify relatively resistant animals. 
 Figure 28. T congolense cultured with peritoneal exudate adherent cells from two mouse 
strains: A/J mice which are relatively susceptible to the parasite in vivo and C57BI which are 
relatively resistant. The cells of the A/J mice maintained T congolense in culture much better 
than the C57BI cells. This difference became more marked when cells were used from mice 
previously infected with the immunostimulator C parvum. 
Effects of trypanosomiasis on the central nervous system 
Cattle and goats infected with T b brucei, may develop a fatal illness characterized by clinical 
abnormalities in the central nervous system. This may occur during the initial infection or after 
treatment with trypanocidal drugs. Two projects were initiated in 1982 to investigate central 
nervous system involvement in T b brucei infecitions. 
In one study, 12 cattle were infected with T b brucei or a mixture of T b brucei and T congolense. 
Sera and fluid were collected and analysed for the presence of antibodies specific to the 
trypanosome clones used. A slight rise in IgM antibodies was observed in the cerebrospinal fluid 
2 months after infection. 
The cattle given mixed infections developed abnormalities in the central nervous system and 
died. In 6 out of 8 of the cattle which died, a mild to moderate meningoencephalitis was 
apparent. Brain tissue from these animals is now being analysed for the presence of immune 
complexes. 
In the second study, eight cattle were infected with T b brucei. Four of these animals died 4 to 6 
months after infection. Despite mild anaemia and intermittent, low-level parasitaemia, they 
became very ill and emaciated and showed typical signs of central nervous system derangement 
as a result of severe meningo-encephalitis. The other four cattle were treated with the 
trypanocidal drug diminazene aceturate. They developed clinical signs after treatment and 
similar lesions were observed in their brains. 
To investigate this syndrome further, 14 East African-Galla crossbred goats were infected with T 
b brucei. Unlike the cattle, they showed persistently high parasitaemia and developed severe 
anaemia. Three animals died 6 weeks after infection. The others were treated and all but one 
appeared to recover, but in the 3rd month after treatment half of the remaining goats developed 
anaemia with signs of central nervous system involvement, as shown in Figure 29. In all cases, 
trypanosomes were present in the cerebrospinal fluid, which also showed increases in protein and 
cell content. Brain tissue from these animals is being examined by electron microscopy to 
determine how the parasites invade the central nervous system. 
 
Figure 29. Development of anaemia in goats infected with T b brucei and treated after 7 wks 
with diminazene aceturate. Fourteen goats were infected intravenously with 106 T b brucei 
(ILRAD 1797) and the course of anaemia measured by changes in packed cell volume (PCV). 
The figure shows mean PCVs up to 24 weeks after infection. Four goats died within 8 weeks, but 
after treatment the PCVs of the others returned rapidly to normal. However, beginning 9 weeks 
after treatment the infections in half the remaining goats relapsed. The average PCV of the 
relapsed group is shown by the broken line in the figure, while the continuation of the solid line 
shows the average PCV of the others. 
Both studies confirm that T b brucei can be pathogenic for domestic livestock. In the second 
study, brain lesions were observed both after primary infections and after treatment with 
trypanocidal drugs. Parasites entering the central nervous system are resistant to the effects of 
many of the trypanocides commonly used to treat livestock because the drugs cannot cross the 
bloodbrain barrier. Thus relapsing infections which occur occasionally after treatment may not 
necessarily be the result of drug resistance or underdosage, but rather may be due to the transfer 
of parasites to the central nervous system and subsequent systemic reinfection. 
Resistance to trypanosomiasis in livestock and wildlife 
Comparative studies on host resistance to trypanosomiasis comprise an important research area 
at ILRAD. One goal is to find genetic markers which can be used to identify relatively resistant 
animals for livestock improvement programs. A better understanding of how some animals resist 
trypanosomiasis may also suggest promising interventions for increasing the resistance of others. 
Previous work has suggested that indigenous East African livestock breeds may possess some 
genetic resistance to trypanosomiasis, though not to the same degree as the recognized West 
African trypanotolerant breeds. Studies are in progress to assess levels of resistance and 
determine the mechanisms involved. 
In 1982, five groups of cattle of different breeds were infected with T congolense by intravenous 
injection. These were Boran and Ayrshire from tsetse-free areas of Kenya and three groups of 
Zebu from different tsetse-endemic zones. The Ayrshires were significantly more susceptible to 
trypanosomiasis than the other groups, followed by the Boran and the two Zebu groups from low 
tsetse-challenge areas, all with similar levels of susceptibility. The Zebu cattle from a high 
challenge area in western Kenya were generally most resistant, but this group showed 
considerable heterogeneity. Resistant animals controlled parasitaemia more effectively and 
developed less severe anaemia. The Ayrshire cattle produced less anti-trypanosome antibody 
than the other four groups. The other groups did not differ significantly in terms of antibody 
production, but antibody activity persisted longer in the more resistant animals. As the three 
Zebu groups had been exposed to trypanosomiasis previously, it was not possible to assess 
whether the resistance they demonstrated was due to innate or acquired factors. 
In a related study, five groups of goats were challenged with T congolense by infected tsetse 
flies-East African goats, Galla and crossbreds of East African with Galla, Nubian and 
Toggenburg. No important differences were observed between these breed groups, either in the 
development of the chancre or in the timing, level or duration of the first parasitaemic wave. All 
groups developed severe anaemia by the 6th week after infection. Immune responses to the 
parasite, measured by immune lysis of bloodstream forms, were also similar for all groups. 
Red Masai sheep from East Africa have been shown to resist trypanosomiasis better than 
imported Merinos. Parasite populations increase just as quickly in the Red Masai, but the 
resulting anaemia is milder. Studies are in progress to determine the reason for this relatively 
mild anaemia, but initial results have been inconclusive. 
It has been observed for some time that wild animals resist trypanosome infection, but little is 
known about the mechanisms involved. ILRAD scientists have carried out several studies on 
resistance in East African wildlife species in collaboration with the Kenya Government's 
National Veterinary Laboratories, supported by the Government of the Netherlands. 
To study the role of the local skin reaction and other responses to trypanosome infection, buffalo, 
oryx, waterbuck, eland, taurine cattle and East African goats were exposed to tsetse flies infected 
with T congolense, T b brucei or T vivax. Among animals exposed to T congolense, chancres 
appeared at 80 to 90% of infected bite sites in the domestic species and at 20 to 60% of bite sites 
in the wild species. The chancres which developed were also larger in the domestic animals. The 
prepatent period before parasites appeared in the bloodstream was generally much longer in the 
buffalo, oryx and waterbuck than in the goats and cattle, and the level of parasitaemia was lower 
in the wild species. All the animals showed some anaemia, as measured by reductions in packed 
cell volume (PCV), but only the domestic animals suffered from severe or chronic anaemia. 
These results, shown in Figure 30, suggest that the greater resistance to T congolense shown by 
the wild species may be related to better control of parasites in the skin and better control of 
anaemia. 
   
% Skin 
reaction at 
bite sites 
% Skin 
thickness 
increase 
Prepatent 
period 
(days) 
Maximum 
parasitaemia 
(parasites/ml) 
% Drop 
in PCV 
Buffalo 20 0 32 102-103 5 
Oryx 20 0 27 104 20 
Waterbuck 60 70 23 104 24 
Eland 40 100 13 106 24 
Cattle 80 200 13 106 37 
Goats 90 300 9 106 50 
Figure 30. Comparison of resistance to trypanosomiasis infection in wild and domestic animals, 
as shown by differences in local skin reaction, development of parasitaemia and level of 
anaemia. Animals were challenged by tsetse infected with T congolense. 
The pattern of reactions was similar among animals exposed to T b brucei. Eland and waterbuck 
developed fewer chancres and less severe anaemia, but the differences between the wild and 
domestic species were less marked than for T congolense. It was not possible to infect the eland 
or water buck with T vivax using tsetse flies, though the animals were fully susceptible to 
intravenous challenge with bloodstream parasites. Further experimentation will determine 
whether this resistance to tsetse challenge is due to responses in the skin or to a resistance to 
metacyclic, as opposed to bloodstream, forms of the parasite. 
When eland, buffalo, waterbuck and cattle were infected intravenously with bloodstream forms 
of T b brucei, the first wave of parasitaemia was similar in all the animals. However, after the 
first wave, parasite levels were considerably lower in the eland and buffalo than in the cattle and 
decreased gradually until parasites could no longer be detected. In the waterbuck, several 
parasitaemic waves occurred, similar to those observed in the cattle. However, anaemia was 
severe in the cattle, but very mild in all three wild species. Clearly, some factor limits parasite 
growth in the bloodstream of eland and buffalo, perhaps responses similar to those detected in 
resistant mouse strains. 
In another study, wildebeest and Boran cattle were infected intravenously with bloodstream 
forms of T b brucei and their antibody responses were compared. Both the wildebeest and the 
cattle produced IgM, IgG1and IgG2 antibodies directed specifically against trypanosome 
antigens, but the cattle produced much lower levels of IgM than the wildebeest. The wildebeest 
produced antibodies in a pattern of recurrent peaks, while the cattle did not. The cattle were able 
to control parasitaemia within 2 months after infection, whereas the wildebeest were still slightly 
parasitaemic after 7 months, but the cattle became anaemic and the wildebeest did not. 
A culture system has been developed which should make it possible to study these reactions in 
more detail. Cell lines were established from embryonic tissue taken from eland, impala, Grant's 
gazelle and goats. These cells lines have been tested in combination with different sera for their 
capacity to support the growth of bloodstream forms of T b brucei and T b rhodesiense. Parasites 
were maintained successfully with feeder layers of eland, impala and goat cells combined with 
sera from the same species, but not with cells of Grant's gazelle. Further experiments are in 
progress to investigate why the parasites could not be maintained with the gazelle cells. The 
success of the other culture systems indicates that tissue and sera from eland and impala have no 
innate factors which inhibit parasite growth. These results support the observation that the 
mechanism which enables eland to control trypanosome growth in the bloodstream is only 
stimulated after an initial parasitaemic wave. 
In vitro studies have demonstrated that the enzyme polyamine oxidase, present in the 
bloodstream of wild and domestic ruminants, suppresses the growth of African trypanosomes in 
the presence of either spermine or spermidine. High levels of polyamine oxidase activity have 
been detected in sera from adult buffalo, cattle, eland, sheep and waterbuck, while none was 
detected in non-ruminant sera. Much lower levels of activity were observed in fetal bovine sera 
than in sera from adult cattle, but activity increased rapidly in newborn calves, reaching adult 
levels on the 21st day after birth. 
Spermidine and putrescine were detected in bloodstream forms of T vivax and T b brucei and in 
procyclic forms of all three major trypanosome species. No spermine was detected. When 
bloodstream and procyclic forms of T b brucei were cultured with bovine serum, the spermidine 
they released was broken down by polyamine oxidase, forming aldehyde which gradually 
decomposed to putrescine. The amount of spermidine in the culture increased for 42 hours and 
then dropped off: at the same time, the population of trypanosome bloodstream forms increased 
for 42 hours and then decreased slightly (see Figure 31). This suggests that the toxic aldehyde 
produced from the breakdown of spermidine may suppress the growth of trypanosomes in 
culture. 
 Figure 31. Bloodstream forms of T b brucei were cultured in HEPES (25mM)-buffered RPMI 
1640 medium with 20% fetal bovine serum at 28°C for 72 h. The number of trypanosomes 
reached a maximum concentration after 48 h and decreased slightly during the next 24 h. 
Likewise, the amount of spermidine released in the culture medium increased up to 48 h and 
decreased considerably during the next 24 h. The amount of putrescine, produced by the 
poiyamine oxidase activity of the serum, increased steadily throughout the 72 h period. 
Epidemiology 
In many field situations in Africa, livestock are exposed to more than one trypanosome species 
and to a large number of genetically distinct parasite populations, called serodemes. The 
development of techniques to identify trypanosome species and serodemes is an important 
component of ILRAD's epidemiology program. The epidemiology program also includes studies 
on the role of tsetse flies as trypanosomiasis vectors. In addition, a field project is being 
conducted at the Kenya coast, and ILRAD scientists are participating in a collaborative research 
project on livestock productivity and trypanotolerance covering sites in several African 
countries. 
Characterization of trypanosome populations 
Scientists are developing techniques to identify trypanosome species based on the analysis of 
antibodies present in the blood of infected animals. Monoclonal antibodies have been raised 
against T congolense and T b brucei parasites and the antigens recognized by these antibodies 
have been isolated using immunoadsorbent columns. Antibodies against these purified antigens 
were readily detected by enzyme-linked immunosorbent assay (ELISA) in sera taken from cattle 
infected with the same trypanosome species, but not in sera from cattle infected with different 
species. Purified T vivax antigens are now being prepared using the same technique and antigens 
from all three species are being characterized biochemically. By detecting antibodies produced 
against these antigens, it is now possible to determine how quickly antibodies are produced after 
trypanosome infection and how long these antibodies persist in the bloodstream after an animal 
recovers. This approach could be extended to identify parasites in tsetse flies. 
Within a trypanosome species, serodemes can also be identified by analyzing antibodies present 
in the blood of infected animals. Experiments using monoclonal antibodies and sera from 
infected rabbits indicate that metacyclic parasites of specific T congolense and T b brucei 
serodemes display a limited number of VSGs about 10 to 12 in the T b brucei serodemes studied 
and 4 to 6 in the T congolense serodemes. These metacyclic VSGs are characteristic and constant 
for each serodeme. 
Cattle chronically infected with bloodstream forms of T congolense or T b brucei produce 
antibodies against metacyclic VSGs of the infecting serodeme, but not against metacyclic VSGs 
of other serodemes. This indicates that bloodstream forms produce VSGs which are the same or 
very similar to metacyclic VSGs of the same serodeme. This study is now being extended to T 
vivax. The long-term objective is to develop techniques which can be used to type trypanosome 
isolates and determine the number of serodemes present in any given field situation. The 
detection of specific antibodies against trypanosome metacyclics may also indicate whether 
animals under field challenge conditions have developed any immunity to the local serodemes. 
Another system is being developed on an experimental basis to identify trypanosome species and 
serodemes by analysing parasite DNA. Two genes which code for specific VSGs have been 
cloned from two well characterized T congolense stocks. Double stranded DNA copies (cDNA) 
have been synthesized from these genes and cloned in bacteria. One of the cDNA clones is being 
used to probe T congolense isolates from various regions of East Africa, primarily by Southern 
blot hybridization, to identify specific serodemes. 
A third approach involves priming animals by infection with one serodeme and treatment, and 
then infecting them with various field isolates and monitoring the appearance of chancres. Goats 
develop chancres when they are primed with one serodeme of T congolense or T b brucei and 
then challenged with isolates of different serodemes, but no chancre develops when they are 
challenged with an isolate of the same serodeme as the original infection. This approach has not 
yet been successful in identifying T vivax serodemes. 
It has also proven difficult to prime experimental animals with more than one serodeme. When 
goats were infected with four T congolense serodemes at 4- or 12-day intervals, the initial 
infection blocked subsequent infections so the animals developed full resistance to the first 
serodeme only. This interference may be due to a nonspecific response to the first infection 
which subsequently limits parasite growth in the skin. Another finding was that goats or cattle 
which were bitten by tsetse flies three or more times developed striking immediate 
hypersensitivity reactions in the skin, as shown in Figure 32, whether the flies were infected or 
not. Scientists are investigating this reaction in more detail to evaluate whether hypersensitivity 
to tsetse saliva affects the transmission of trypanosomes. 
 
Figure 32. The skin of a goat showing a severe hypersensitivity reaction 48 h after being bitten 
by an uninfected tsetse fly. This animal had been bitten on two previous occasions. There is 
extensive superficial necrosis of the epidermis and marked cellular infiltration of the dermis 
accompanied by severe oedema. 
A special problem in trypanosomiasis epidemiology relates to the distinction between T b brucei 
which infects several species of domestic livestock, and T b rhodesiense, which infects humans. 
These two trypanosome subspecies are morphologically indistinguishable. Experiments have 
been carried out at ILRAD to identify T b brucei and T b rhodesiense infections by analysing 
parasite DNA with restriction enzymes. This work has been successful, but DNA analysis 
requires long and complex purification procedures which limits its usefulness under field 
conditions or for large-scale studies. For this reason, a simplified laboratory technique is being 
developed which can be used to identify different trypanosome species from samples of blood, 
tsetse saliva or isolated cells, as illustrated in Figure 33. Work is now in progress to develop a 
similar test which will distinguish the subspecies T b brucei and T b rhodesiense, and also T b 
gambiense, the other trypanosome subspecies which infects humans. 
 
Figure 33. Simplified illustration of a molecular hybridization technique for parasite 
identification. Suspensions of whole trypanosomes of four different stocks—T b brucei ILTat 1.3, 
T b brucei ILTat 1.2, T b brucei LUMP 427 and T b rhodesiense ETat 1.10—were diluted to 
different levels and applied to nitrocellulose filters. The filters were processed by the Southern 
blot method and the trypanosomes were hybridized with a probe for T b brucei ILTat 1.3 DNA. 
The figure shows that hybridization occurs only with parasites related to the specific probe. The 
degree of hybridization increases (darker spot) as the number of parasites increases. The method 
should be useful to distinguish the presence or absence of trypanosomes of a specific genotype, 
provided there is a minimum of 104 parasites in the sample. 
The infectivity of different parasites for different host species may be linked to survival in the 
host bloodstream. Successive generations of T b rhodesiense populations have been observed 
which vary in terms of their sensitivity or resistance to the cytotoxic effects of human serum in 
vitro. This could indicate a variation in their potential viability in the human bloodstream. The 
reversibility of this sensitivity suggests that it is mediated by some protein or proteins which are 
synthesized in response to changing genetic information. ILRAD scientists have searched for 
differences in protein configurations between serum-sensitive and insensitive T b rhodesiense 
preparations using two-dimensional gel electrophoresis. However, no consistent differences have 
been detected yet. 
Scientists have also observed a reversible pattern of sensitivity to human serum in T b brucei 
parasites isolated from laboratory animals and livestock. A cow was infected with a stock of T b 
brucei (TREU 667) which had previously been sensitive to the cytotoxic effects of human serum. 
Parasites appeared in the animal's bloodstream and cerebrospinal fluid. In vitro tests showed that 
parasites from the bloodstream were sensitive to human serum, while parasites from the 
cerebrospinal fluid were not. This suggests that T b brucei parasites which resist cytotoxicity in 
human serum may have an affinity for the central nervous system. Goats were infected with 
another derivative of this stock and parasites isolated from the bloodstream, the cerebrospinal 
fluid and the brain tissue all resisted the cytotoxic effects of human serum. Material has been 
collected which will be used to investigate whether changes in parasite sensitivity might be 
related to the expression of different surface antigens. 
Studies on tsetse flies as trypanosome vectors 
Tsetse studies at ILRAD concentrate on exploring improved methods for trypanosomiasis 
control. For instance, the release of sterile male tsetse flies has aroused considerable interest as a 
potential method of tsetse eradication. The success of this approach is based on the fact that 
female tsetse normally mate only once in their lifetime, so if most or all of the female flies in an 
area mate with sterile males the population will be eradicated. However, the possible impact on 
trypanosomiasis epidemiology of releasing large numbers of sterile males has not been fully 
explored. 
Investigations in 1982 focused on the infection rates and transmission characteristics of male 
tsetse flies sterilized by gamma irradiation. Sterile and fertile males of three species-Glossina 
morsitans centralis, G austeni and G tachinoides—were fed on a goat infected with T b brucei 
and their survival rates, mating performance and transmission characteristics were compared. 
Ninety percent or more of the flies exposed to gamma irradiation were found to be sterile, but 
their mating performance was similar to that of fertile males. Differences in trypanosome 
infection rates between sterile and fertile males were marginal, and there were no differences in 
transmission characteristics between the two groups. These findings indicate that the release of 
sterile males as part of a tsetse control program could increase the immediate risk of 
trypanosomiasis. Similar studies are now in progress to examine the transmission of T 
congolense and T vivax by sterile male tsetse. 
Another study concentrated on the possible impact on tsetse infection rates of treating livestock 
with trypanocidal drugs. A population of G m morsitans was fed on a goat infected with T vivax.. 
The flies were then divided into three groups and each group was maintained on a different goat, 
one treated with Berenil, one treated with isometamidium (Samorin-May and Baker) and one 
untreated control. The experiment was repeated using goats infected with T congolense and T b 
brucei, and the survival, fecundity and infection rates of all the flies were compared. 
No significant differences were detected in survival rates or reproductive performance, but 
infection rates were significantly reduced for all groups of tsetse maintained on goats treated 
with trypanocidal drugs, as shown in Figure 34. This suggests that a carefully managed drug 
treatment program could significantly reduce the cyclical transmission of trypanosomiasis in 
situations where tsetse are largely feeding on livestock. 
Original 
infection 
Number 
infected 
Maintained on 
goats treated 
with: 
Number 
survived 
Infection rates 
in surviving 
tsetse (%) 
T vivax 200 Berenil 142 2.1 
T vivax 200 Samorin 82 0.0 
T vivax 200 Control 131 97.7 
T congolense 200 Berenil 79 19.0 
T congolense 200 Samorin 50 14.0 
T congolense 200 Control 28 46.4 
T b brucei 200 Berenil 89 0.0 
T b brucei 200 Samorin 102 0.0 
T b brucei 200 control  109 22.0 
Figure 34. Comparison of T vivax, T congolense and T b brucei infection rates in male and 
female G m morsitans infected as tenerals and then maintained on goats treated with Berenil or 
Samorin or on untreated control animals. 
To support epidemiological research in the field, a serological system has been developed to 
identify the animal species on which tsetse flies have fed. Such a system has to be specific 
enough to differentiate closely related host species and sensitive enough to analyse even the 
minute quantities of blood which can be obtained from the flies. Antisera were prepared against 
42 species of mammals and 4 species of birds. To test their specificity, bloodmeals were 
analysed from tsetse flies raised at ILRAD. Further work will concentrate on the production of 
species-specific monoclonal antibodies which could provide a steady source of standard antisera. 
In collaboration with the Swiss Tropical Institute, scientists completed a study on changes in the 
ultrastructure and function of secretory cells in the tsetse uterine gland at different stages of 
pregnancy. Material taken from G m morsitans raised at ILRAD was examined in Basel by 
electron microscopy. This study demonstrated a temporal correlation between cellular dynamics 
and physiological events during pregnancy. The goal is to identify possible approaches to the 
control of tsetse populations by interfering with the reproductive process. 
Epidemiological survey at the Kenya coast 
An epidemiological survey was conducted in 1982 at a large dairy ranch near the Kenya coast. 
This location was chosen for an intensive study because the trypanosomiasis situation appeared 
fairly simple, with a low level of disease risk and little movement of livestock or wild animals. 
A preliminary tsetse survey was carried out using bait oxen, biconical tsetse traps and searches 
for tsetse pupae and pupal cases. This survey revealed a small population of G austeni on the 
ranch in an area of dense riverine bush. Of 28 tsetse captured, 26 were dissected and 5 were 
found to be infected with trypanosomes: 2 with T vivax and 3 with T congolense. Four tsetse 
bloodmeals were analysed using antisera prepared at ILRAD. These were found to originate 
from a sheep, a cow, a warthog and a suni (Neotragus moschatus). 
Blood samples were taken from a total of 5909 cattle on the farm. Of these, 1890 (32%) were 
anaemic, with a PCV of 30% or less. Twenty-five animals were found with trypanosome 
infections: 22 with T congolense, 2 with T b brucei and 1 with T vivax. Nearly all the infected 
cattle were kept near the area where the tsetse flies had been captured. 
Twenty tracer cattle were brought to the tsetse-infested area and kept in an open pen. Fourteen of 
these became infected with T congolense about 22 days after exposure and were treated with 
Berenil. About 60 days after treatment, 16 animals became infected, including 13 reinfections 
and 3 first infections, and these were treated again. One animal became infected 3 times. 
Collaborative epidemiology network 
ILRAD scientists are collaborating with colleagues at ILCA and ICIPE in a research and training 
network which includes projects in 11 countries of West, Central and East Africa, as shown in 
Figure 35. ILRAD's role is to provide training and supervision for the animal health and tsetse 
survey components of the program. 
 Figure 35. Eleven countries in Africa where ILRAD is collaborating with ILCA and ICIPE in 
evaluating the impact of trypanosomiasis on livestock production. Major research sites are 
located in countries where trypanotolerant cattle are raised. 
The main focus of the program is on the indigenous taurine cattle breeds of West and Central 
Africa, the N'Dama (shown on the cover) and West African Shorthorn, which are significantly 
more resistant to trypanosomiasis than Bos indicus or European Bos taurus breeds. This trait, 
termed trypanotolerance, has been shown to be an innate characteristic. Comparative studies on 
these and other breeds are in progress in Ivory Coast, Nigeria, Zaire and Gabon and will be 
extended in 1983 to The Gambia, Senegal, Togo, Congo and Benin. Carefully selected 
production situations are being monitored where different breeds of cattle, sheep and goats are 
being raised under well defined management regimes and levels of trypanosomiasis risk. Similar 
studies are under way in Kenya and Tanzania focusing on indigenous breeds of cattle, sheep and 
goats. 
  
Research Support 
 Tsetse Laboratory 
Breeding colonies of 8 tsetse species were maintained at ILRAD in 1982, providing a good 
representation of the 30 species and subspecies found in tropical Africa. Colonies of G m 
centralis, G m morsitans, G austeni, G tachinoides, G palpalis palpalis, G fuscipes fuscipes, G 
brevipalpis and G pallidipes are maintained. All these species are being evaluated in terms of 
their capacity to transmit T vivax, T congolense and T b brucei to ruminants. 
Tsetse flies raised at ILRAD are used for research on the role of tsetse as trypanosomiasis 
vectors and for collaborative research projects with other ILRAD scientists. In addition, 16,613 
tsetse puparia and adult flies were supplied in 1982 to research centres in Kenya, Togo, Zambia, 
Austria and Switzerland. 
The colony of G m centralis, originating from Singida in Tanzania, has been stabilized at a level 
of about 10,000 breeding females. This colony provides material for most trypanosomiasis 
research at ILRAD involving use of the vector. The G m morsitans colony, originating from the 
Kariba region of Zimbabwe, comprises about 1500 breeding females. The G austeni colony, 
originating from Zanzibar, and the G tachinoides colony, originating from Chad, are both 
maintained at a level of about 2000 breeding females. 
A colony of G p palpalis was established in May 1982 from 1000 puparia received from IAEA in 
Vienna. The population originated in Nigeria. The performance of this colony has been good; the 
target breeding population of just over 2000 females was reached at the end of November. 
Two colonies of G f fuscipes were established in 1982. One originated from wild flies and 
puparia collected in a forest on the shore of Lake Victoria in Uganda. This colony rose to 1300 
breeding females by March 1982, declined rapidly and then began to increase again. The goal is 
to reach a breeding population of 1000 females in 1983. The other G f fuscipes colony was 
established in June 1982 with 500 puparia received from the Institut d'Elevage et de Médecine 
Vétérinaire des Pays Tropicaux (IEMVT) in France. This stock originated from the Central 
African Republic. The number of breeding females had risen to 980 by the end of the year. 
A colony of G brevipalpis was initiated in April 1982, originating from wild flies caught in the 
Kibwezi forest in Kenya. The breeding population increased gradually to 411 females by the end 
of November. A colony of G pallidipes was also established in April, originating from wild 
females caught in the Kibwezi forest. This colony fluctuated at around 250 females, but flies 
were then mated at an older age and breeding performance improved. 
Tick Laboratory 
ILRAD's tick laboratory maintains breeding colonies of two strains of Rhipicephalus 
appendiculatus, the vector for T p parva and T p lawrencei, and one strain of Amblyomma 
variegatum, the tick species which transmits T mutans. The tick laboratory routinely provides 
ILRAD scientists with infected and uninfected ticks, tick salivary glands and other organs and 
tick-derived Theileria stabilates. In 1982, Theileria sporoblasts and sporozoites were harvested 
from over 40,000 infected ticks. 
Several factors which affect tick growth, survival and infection rates are being assessed, 
including different tick strains, temperature conditions, different animal species and breeds used 
for tick feeding, the timing of feeding, the level of crowding and environmental factors 
influencing the host animal. The goal is to produce large numbers of ticks with as many parasites 
as possible. Staff from the tick laboratory also test the infectivity of tick-derived Theileria 
stabilates and monitor the course of experimental infections in cattle. 
In addition to supplying tick and parasite material to scientists at ILRAD, in 1982 the tick 
laboratory supplied ticks to the Kenya National Veterinary Laboratories and the Veterinary 
Research Department of the Kenya Agricultural Research Institute. 
Farm Animal Production 
Scientists at ILRAD used about 400 cattle for research projects in 1982. About 85% of these 
were used for ECF research and 15% for work on trypanosomiasis. 
ILRAD purchased a 13,000 ha ranch at the end of 1981 on the Kapiti plains about 80 km from 
Nairobi. Over 2000 Boran (Bos indicus) cattle were purchased with the ranch, including a 
breeding herd of 750 mature cows and 220 heifers. During the year, cattle handling facilities and 
water supplies were improved and housing was constructed for some of the ranch staff. To 
improve tick control on the ranch, a new spray race was installed and an existing one was 
renovated. By the end of the year, the breeding herd had grown to 786 mature cows and 595 
heifers. 
The ranch at Kapiti supplied ILRAD's research program with 335 calves and steers in 1982. 
Another 26 calves were bred at ILRAD, and 26 Bos taurus cattle were purchased from other 
ranches in Kenya for experiments which required these breeds. With the purchase of the ranch 
and expansion of cattle holding facilities at ILRAD, a steady supply of Bos indicus cattle was 
assured throughout the year. The supply of taurine cattle was interrupted for a period, however, 
when movement restrictions were imposed in Kenya due to an outbreak of foot-and-mouth 
disease. 
Most research work involving cattle was carried out at Kabete, but 28 animals were taken to 
Kilifi as part of the ECF epidemiology project. Ten Zebu cattle were used for a collaborative 
trypanosomiasis research project, housed at the Kenya Veterinary Research Laboratories near 
ILRAD. 
ILRAD scientists used about 400 small ruminants in 1982, including 370 goats and about 30 
sheep. These animals are of local East African breeds, purchased from the area around ILRAD. 
In 1982, 95% were used for trypanosomiasis research. The screened accommodation available at 
ILRAD for trypanosomiasis experiments can accommodate 300 small ruminants. These facilities 
were used to capacity in 1982. Expansion of the trypanosomiasis epidemiology program may 
require the construction of additional fly-proof housing. 
Laboratory animal production 
ILRAD's laboratory animal unit maintains breeding populations of mice, rats and rabbits, and 
small colonies of guinea pigs and gerbils. The mouse breeding program expanded from 5 inbred 
strains in 1981 to 12 strains in 1982. A total of 43,392 mice were produced in the course of the 
year, supplying all of ILRAD's research needs. Mice are used primarily to study the mechanisms 
of resistance to trypanosomiasis, as important genetic differences exist between inbred strains in 
terms of immune and other responses to the parasites. A random-bred strain of nude mice was 
imported in 1982, and a breeding program was initiated to develop inbred nude mouse strains. 
These are hairless animals with no thymus glands. Because their cell-mediated immune 
responses are inhibited, they are useful hosts for investigating the course of trypanosome 
infections and for comparative, studies with other mouse strains. However, because of their poor 
disease resistance, maintenance requirements are very high, and procedures in ILRAD's breeding 
unit have been modified accordingly. 
One inbred rat strain is maintained, primarily to produce the trypanosomes required by ILRAD 
scientists. A strain of larger rats was introduced in 1982, replacing the strain used previously. 
During the year, a total of 25,075 rats were produced, sufficient for all of ILRAD's research 
needs. 
Rabbits are bred primarily to support the tsetse and tick colonies. For this purpose, a new line of 
full-lop-eared rabbits has been introduced from the UK. A few rabbits are also used to produce 
sera for research and diagnostic purposes. Altogether, 450 rabbits were produced in 1982. 
In addition to supplying nearly all the laboratory animals used at ILRAD, the breeding unit 
donated animals to a number of other research institutes. In 1982, these included ICIPE, the 
Kenya Trypanosomiasis Research Institute, the University of Nairobi, the National Museums of 
Kenya and an FAO project in Zambia. 
Clinical and diagnostic Services 
The diagnostic laboratory carries out several types of routine analysis for the research 
laboratories and animal production facilities. In 1982, 26,014 samples were received for analysis, 
more than twice the number received in 1981. These included 17,246 samples for serological, 
5473 for bacteriological, 2284 for haematological and 1011 for helminthological analysis. This 
substantial increase in number of analyses performed in 1982 was due to the expanded ECF 
epidemiology project at the Kenya coast and an outbreak of salmonellosis which occurred in the 
cattle holding units at ILRAD. 
Serological screening and titration were provided for antibodies to six bloodstream parasites 
found in cattle—T p parva, T mutans, T b brucei, T congolense, T vivax and Anaplasma 
marginale. Most routine screening for the Theileria and Trypanosoma species was by IFA test. 
The ELISA test was also used to screen bovine sera for the three species of trypanosome. The 
card agglutination test was used to screen sera for A marginale antibodies. 
During the year, 210 post-mortem examinations were carried out in the course of 
trypanosomiasis and ECF investigations. These included 111 cattle, 88 goats, 7 sheep and 4 
animals of other species. Cases of salmonellosis, infectious bovine rhinotracheitis and muscular 
dystrophy were encountered in cattle, as well as the diseases under study. Urolithiasis and 
coccidiosis were found in goats. 
In addition to services provided to ILRAD scientists, the diagnostic laboratory continued to assist 
other centres and projects in developing countries. T p parva schizont antigens, positive and 
negative control sera, and goat antibovine IgG and IgM conjugate were provided to the National 
Veterinary Laboratory in Uganda and to FAO projects in Burundi and Mozambique. Tests for 
Theileria and Trypanosoma antibodies were performed for a German (Federal Republic) 
technical aid project in Somalia. 
  
Training and Information Services 
ILRAD's training program is designed to support the development of scientific and field 
personnel who can extend research on trypanosomiasis, theileriosis and other pressing veterinary 
problems—primarily in Africa, but also in other parts of the world. Scientists and technicians are 
trained to carry out the most effective disease control programs possible with the means currently 
available. At the same time, they are prepared to initiate new field programs when improved 
control methods are ready for introduction. 
Participants in the training program work closely with scientific staff within the scope of 
ILRAD's research mandate. Training opportunities are steadily increasing for scientists and 
senior technicians, post-graduate students and post-doctoral fellows, based on the availability of 
supervisory staff, laboratory space, equipment and accommodation. 
In 1982, 14 scientists and technicians came to ILRAD for specialized training, for periods lasting 
from 1 week up to 1 year. Thirteen came from 9 African countries and 1 from India, and all were 
staff members of national universities, veterinary laboratories or research centres. Their training 
programs were planned on an individual basis according to the needs of their home institutes. 
Three Kenyans from the Ministry of Livestock Development received training, two in basic 
haematological and parasitological techniques and one in the dissection of Theileria-infected 
ticks. One staff member from the Uganda Trypanosomiasis Research Organization was trained in 
histological techniques and another learned methods for maintaining laboratory animals. Two 
Zambians from the National Council for Scientific Research came to ILRAD to learn 
parasitological techniques relating to ECF. One Zairean from the Laboratoire de Parasitologie of 
the Université Nationale de Zaire was trained in parasitological and diagnostic techniques related 
to trypanosomiasis, and a Zimbabwean from the Veterinary Research Laboratory learned how to 
maintain Theileria parasites in culture. The head of the Parasitology Department at Addis Ababa 
University in Ethiopia received training in parasitological techniques related to trypanosomiasis, 
and a scientist from the Nigerian Institute for Trypanosomiasis Research learned techniques for 
maintaining T vivax in culture. A staff member from the Laboratoire Central Vétérinaire in Mali 
was trained in immunolgical and parasitological techniques, and a member of the Immunology 
Department of the University of Yaoundé in Cameroon received training on antigenic variation 
in trypanosomes, supported by the World Health Organization (WHO). From India, a professor 
of parasitology at Punjab Agricultural University received training in basic cell culture and 
specific techniques for cultivating Theileria parasites in vitro. 
Fifteen post-graduate students worked with ILRAD scientists in 1982 on projects closely linked 
with ILRAD's research program. Post-graduate students are registered in a higher degree 
program, most often at the University of Nairobi. They work at ILRAD from 1 to 3 years and 
submit their projects as part of their degree requirements. In 1982, 10 students in this category 
came from Kenya, 2 from Uganda, and 1 each from Rwanda, Australia and Belgium. 
Post-doctoral fellows are selected internationally, though emphasis is placed on recruiting well-
qualified young scientists from African countries. They normally spend 2 years at ILRAD, and 
their work is expected to contribute directly to the research program. In 1982, 11 post-doctoral 
fellows worked at ILRAD, including 2 from Germany (Federal Republic), 2 from the UK and 1 
each from Kenya, Uganda, Zaire, India, Belgium, Japan and the USA. 
Altogether in 1982, 40 students, scientists and technicians received individual training at 
ILRAD, 8 more than in 1981. Thirty of these trainees were from African countries, including 5 
from francophone Africa. 
In addition to training opportunities offered on an individual basis, a 6-week training course was 
held at ILRAD in October and November on the 'Use of Immunological Methods in the 
Diagnosis of Protozoan Diseases'. Fourteen participants attended this course from 10 African 
countries, including 5 from Kenya and 1 each from Liberia, Mali, Nigeria, Senegal, Sudan, 
Tanzania, The Gambia, Uganda and Zambia. The participants reviewed basic biochemical and 
immunological concepts with ILRAD scientists and learned how to produce antibodies, isolate 
and purify immunoglobulins, assess specificities, prepare antigens and cultivate different parasite 
species. They were also taught to perform a range of serodiagnostic tests, with emphasis on the 
diagnosis of protozoan parasites. 
ILRAD scientists helped conduct a 10-week training course in 1982 in collaboration with 
colleagues from ILCA and ICIPE. This was the first of a series of training sessions for field staff 
taking part in the ILCA/ILRAD livestock productivity and trypanotolerance research network. 
The course covered the extraction, analysis and interpretation of data on animal production in 
areas under trypanosomiasis risk. Four scientists participated in this session, one from Ethiopia 
and three from Zaire, and one participant from Nigeria received the same training on an 
individual basis earlier in the year. A training manual, 'Livestock Productivity and 
Trypanotolerance', was prepared in English and French in connection with the course. 
ILRAD's training program provided support for three scientists to attend a 1-week Workshop on 
'Trypanotolerance and Animal Production', held in Avetonou, Togo in May 1982. The workshop 
was sponsored by the Centre de Recherche et d'Elevage, the Government of Togo and the 
German (Federal Republic) Agency for Technical Cooperation and Foundation for International 
Development. One of the participants sponsored by ILRAD came from Senegal, one from The 
Gambia and one from Uganda. 
The ILRAD library maintains a specialized collection of scientific literature, comprising about 
2400 books, subscriptions to 198 periodicals, and a selection of maps and materials on 
microfiche. The library is used by ILRAD scientists and trainees and by researchers working at 
other institutions in the Nairobi area, including ICIPE, the University of Nairobi, the Kenya 
National Veterinary Laboratories, the Kenya Trypanosomiasis Research Institute, and the 
Veterinary Research Department of the Kenya Agricultural Research Institute. 
The international periodicals are probably the most important component of the library 
collection. Journals are received by air every week, covering topics in such fields as 
parasitology, immunology, biochemistry, entomology, cell biology and veterinary medicine. 
Many of these are not available in any other library in Kenya. Local scientists have access to 
these journals in the ILRAD library or through an active inter-library loan system. Through this 
system, ILRAD scientists also have access to other libraries in the area, some of which are 
associated with older research institutions and thus have collections going back for many years. 
If staff members require articles which are not available locally, these are purchased from the 
British Library Lending Division. 
In 1982, the scientific staff published 35 articles in international journals, 1 chapter in a book and 
2 papers in conference proceedings. The 1981 annual report was prepared in English—and for 
the first time in French—and a series of brochures was issued in both languages describing 
ILRAD's research and training activities and listing all scientific publications. In addition, 
ILRAD's communications staff prepared press releases and articles for outside publication and 
arranged for coverage of ILRAD's research activities on Kenya television. Articles and 
conference papers published by ILRAD scientists are kept in the library, and copies distributed 
on request. Exchanges of publications with other specialized libraries have expanded steadily 
since ILRAD's library was established in 1976. 
The regular seminar series continued in 1982, with sessions held every 2 weeks. These were well 
attended by scientists from ILRAD, the University of Nairobi and other national and 
international research centres in the area. ILRAD staff members also participated in numerous 
international conferences and gave lectures on trypanosomiasis and theileriosis research to 
participants in training courses sponsored by other organizations. 
ILRAD's research and training activities were presented to a large audience in September 1982 in 
an exhibit prepared for the Nairobi International Show. This show is sponsored every year by the 
Agricultural Society of Kenya. Thousands of people visited ILRAD's exhibit from all over 
Kenya. 
ILRAD staff members have played a key role in setting up the Nairobi Cluster, an informal 
organization of University departments, government laboratories and research institutes working 
on trypanosomiasis and ECF in Kenya. Eleven institutions in the Nairobi area are members. The 
Cluster issued a newsletter in 1982 and sponsored a scientific meeting on 'Strategies and Recent 
Developments for the Control of Trypanosomiasis and East Coast Fever', held at ILRAD. The 
meeting was opened by the Minister for Livestock Development, the Hon Mr. Paul Ngei. 
Participants included scientists, government officials, livestock producers, veterinarians and 
representatives of drug companies. 
Research projects were carried out in collaboration with agencies and organizations in many 
parts of the world. In Kenya, ILRAD scientists were involved in research and technical 
collaboration with the Ministry of Livestock Development, ICIPE, the Veterinary Research 
Laboratories, the Veterinary Research Department of the Kenya Agricultural Research Institute, 
the Kenya Trypanosomiasis Research Institute, the OAU's Interafrican Bureau for Animal 
Resources, ILCA, the University of Nairobi's Faculties of Medicine and Veterinary Medicine 
and the Clinical Research Centre of the Kenya Medical Research Institute. Research was also 
conducted in collaboration with the Centre de Recherche et d'Elevage in Togo, the Centre de 
Recherches sur les Trypanosomiases Animales in Upper Volta and the national veterinary 
laboratories of Burundi, Malawi, Mozambique, Rwanda, Tanzania, Zambia and Zimbabwe. 
Outside Africa, ILRAD scientists collaborated with colleagues at the Prince Leopold Institute for 
Tropical Medicine, the Vrije Universiteit Brussel and the Libre Universite de Bruxelles in 
Belgium, the Swiss Tropical Institute, Cambridge, Glasgow and Edinburgh Universities in the 
UK and the Universities of California, Iowa and Washington State in the USA. Several 
collaborative projects are described in the text of this report. 
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Rattansi Educational Trust Building 
Monrovia/Koinanage Street 
P O BOX 41968 
Nairobi, Kenya 
Telephones 20891, 20418, 335362 
Telex 22140 
Cables "Chunga Nairobi" 
Report to the Management of the International Laboratory for Research on Animal Diseases 
(ILRAD) On Internally Prepared Accounting Information Relevant to the Financial Years Ended 
31 December 1981 and 1982 
From a detailed examination of the accompanying schedules (Figure 36 and Figure 37) we can 
confirm that the information contained therein has been extracted from the books and records of 
ILRAD from which statutory accounts were prepared for the financial years ending 31 December 
1981 and 1982. 
Whereas the analysis of financial data in the accompanying schedules differs in some respects 
from that disclosed in the statutory accounts, the key figures remain consistent with the audited 
financial statements at 31 December 1981 and 1982. 
Price Waterhouse 25 March 1983 
Certified Public Accountants 
Figure 36. Summary of costs by program and activity (US$ '000). 
   
   1982 1981 
Research 
Parasitology-Trypanosomiasis 446 469 
Biochemistry 483 554 
Cell Biology 382 344 
Immunobiology 285 455 
Parasitology-Theileriosis 449 493 
Pathology 448 483 
Tsetse Laboratoy 301 312 
Tick Laboratory 93 76 
Electron Microscopy 129 117 
Collaborative Research 142 64 
Total Research 3158 3367 
Research Support 
a. Farm Animal Production 573 458 
Laboratory Animal Production 131 28 
Clinical and Diagnostic Service 63 84 
Radio Isotope and Central Core Services 400 303 
Total Research Support 1167 973 
Training and Conferences 526 301 
Library and Information Services 267 166 
Administration 
b. Board of Directors 70 81 
Office of the Director General 319 416 
Finance 379 509 
Personnel 73 54 
Purchasing 257 223 
Total Administration 1098 1283 
General Operations 
 Engineering 523 536 
Transport 185 206 
Services 275 313 
Food and Housing 33 233 
Stores 54 67 
Total General Operations 1070 1355 
Contingency 166 - 
Total Core Costs 7452 7445 
Special Project - Netherlands 141 123 
 Figure 37. Summary of sources and application of funds (US$ '000). 
   1982 1981 
Core Operating Funds 
Unrestricted 
World Bank (IBDR) 280 1910 
Germany (Federal Republic) 717 770 
United Kingdom 559 540 
Canadian International Development Agency 
(CIDA) 
545 505 
Switzerland 391 412 
Norway 325 380 
Belgium 185 258 
Rockfeller Foundation - 100 
Netherlands 295 230 
Australia 286 265 
Sweden 200 185 
Ireland - 100 
International Atomic Energy Agency (IAEA) 5 - 
Balance From Previous Year 2648 2131 
Earned Income Applied in Year 101 184 
Total Unrestricted Operating Funds 6534 7970 
Restricted 
United States Agency for International 
Development (USAID) 
2400 3100 
United Nations Development Fund (UNDP) 799 694 
Belgium 99 77 
Total Restricted Operating Funds 3298 3871 
Total Unrestricted/Restricted Operating Funds 9835 11841 
Transfer to Capital/Funds (1550) (1749) 
Net Unrestricted/Restricted Operating Funds 8285 10092 
Capital Funds 1550 1749 
d. Transferred from Core Operating Funds 45 637 
Unexpended Balance from Previous Year 709 709 
Total Capital Funds 2304 3095 
Special Project-Netherlands 60 52 
Total Funds 10649 13239 
 
